Multilevel Interventions Demonstrate Mixed Effectiveness for Improving Blood Pressure Outcomes: A Rapid Review
Abstract
1. Introduction
- (1)
- What types of multilevel interventions exist to improve BP among community-dwelling adults aged 18 years+ in the United States (U.S.)?
- (2)
- What is the treatment efficacy on BP?
2. Methods
3. Data Sources
4. Inclusion and Exclusion Criteria
5. Data Extraction
6. Data Synthesis
7. Results
8. Sample Characteristics
9. General Characteristics of the Multilevel Interventions
9.1. Individual and Healthcare Team (47 RCTs and 2 Follow-Ups)
9.2. Individual and Healthcare Team and Health Policy (15 RCTs and 0 Follow-Ups)
9.3. Individual and Community Environment (9 RCTs and 0 Follow-Ups)
9.4. Individual and Family (6 RCTs and 1 Follow-Up)
9.5. Individual and Family and Healthcare Team (4 RCTs and 0 Follow-Ups)
9.6. Healthcare Team and Health Policy (3 RCTs and 0 Follow-Ups)
9.7. Individual and Healthcare Team and Community Environment (2 RCTs and 1 Follow-Up and 1 Subgroup Analysis)
9.8. Individual and Community Environment and Health Policies (2 RCTs and 0 Follow-Ups)
9.9. Individual and Health Policy (1 RCT and 0 Follow-Ups)
9.10. Individual and Family and Healthcare Team and Community (1 RCT and 0 Follow-Ups)
10. Discussion
11. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix A
Appendix A.1. Search Terms by Database
Database | Search Terms |
Cochrane Library | “Hypertension” OR “blood pressure” AND “intervention” OR “trial” AND “adult” Additional filters: Content type = Cochrane reviews; trials No date restriction “Search Word Variations” selected Cochrane Group = Hypertension Note: This database was searched to identify whether a similar review has been undertaken. Relevant reviews will be used to conduct hand searches for additional articles, if available. |
EMBASE | (‘hypertension’/exp OR hypertension OR ‘blood pressure’) AND (‘hairdresser’ OR ‘diet therapy’ OR exercise OR ‘health coaching’ OR ‘public health’ OR ‘prevention and control’ OR ‘lifestyle’) AND english:la AND adult AND ([controlled clinical trial]/lim OR [randomized controlled trial]/lim) AND ([adult]/lim OR [aged]/lim OR [middle aged]/lim OR [very elderly]/lim OR [young adult]/lim) AND ‘article’/it |
PsycINFO | MA “hypertension” OR TX (blood pressure or hypertension or hypertension or htn or elevated blood pressure) AND TX multilevel intervention OR TX lifestyle intervention OR TX health coach OR MA barber* OR TX (diet or nutrition or food habit or eating habit or lifestyle or food) OR TX (exercise or physical fitness or physical activity or exercise therapy) OR TX community health Search Limiters: Peer reviewed, publication type: peer reviewed journal; English language; Language: English; Age Groups: Adulthood (18 yrs & older), Young Adulthood (18–29 Years), Thirties (30–39 yrs), Middle Age (40–64 yrs), Aged (65 yrs & older), Very Old (85 yrs & older); Population Group: Human; Methodology: CLINICAL TRIAL; Exclude dissertations Search Expanders: Apply related words; also search within full text of the articles; apply equivalent subjects Search Modes: Boolean/phrase |
PubMed | ((adult[Filter] OR middleagedaged[Filter])) AND ((((Hypertension[MH] OR Blood Pressure[MH] or Cardiovascular Health[MH]) OR (“Life’s Simple 7”[tw] or “Life’s Simple Seven”[tw] OR “Essential 8”[tw] OR “systolic”[tw] or “diastolic”[tw])) AND (Antihypertensive Agents/therapeutic use*[mh] OR Barbering*[MH] OR Cardiovascular Diseases/prevention & control [MH] OR Preventive Health Services [MH] OR Health Promotion/methods* [MH] OR “barber*”[tw] OR “salon”[tw] OR “health coach*”[tw] OR “Exercis*”[tw] OR “diet*”[tw] OR “lifestyle”[tw] OR “life style”[tw] OR “life-style”[tw] OR “nontraditional health care”[tw] or “multilevel”[tw] OR “multi-level”[tw] OR “communit*”[tw] AND clinical trial[publication type] or random*[title/abstract])) AND (“intervention”)) Note: * indicates wildcard term |
Appendix A.2. PRISMA Checklist
Section and Topic | Item # | Checklist Item | Location Where Item Is Reported |
TITLE | |||
Title | 1 | Identify the report as a systematic review. | 1 |
ABSTRACT | |||
Abstract | 2 | See the PRISMA 2020 for Abstracts checklist. | 2 |
INTRODUCTION | |||
Rationale | 3 | Describe the rationale for the review in the context of existing knowledge. | 5 |
Objectives | 4 | Provide an explicit statement of the objective(s) or question(s) the review addresses. | 5 |
METHODS | |||
Eligibility criteria | 5 | Specify the inclusion and exclusion criteria for the review and how studies were grouped for the syntheses. | 6–7 |
Information sources | 6 | Specify all databases, registers, websites, organizations, reference lists and other sources searched or consulted to identify studies. Specify the date when each source was last searched or consulted. | 6 |
Search strategy | 7 | Present the full search strategies for all databases, registers and websites, including any filters and limits used. | Appendix A.1 (p. 26) |
Selection process | 8 | Specify the methods used to decide whether a study met the inclusion criteria of the review, including how many reviewers screened each record and each report retrieved, whether they worked independently, and if applicable, details of automation tools used in the process. | 6–8 |
Data collection process | 9 | Specify the methods used to collect data from reports, including how many reviewers collected data from each report, whether they worked independently, any processes for obtaining or confirming data from study investigators, and if applicable, details of automation tools used in the process. | 7–9 |
Data items | 10a | List and define all outcomes for which data were sought. Specify whether all results that were compatible with each outcome domain in each study were sought (e.g., for all measures, timepoints, analyses), and if not, the methods used to decide which results to collect. | 7–8 |
10b | List and define all other variables for which data were sought (e.g., participant and intervention characteristics, funding sources). Describe any assumptions made about any missing or unclear information. | 8 | |
Study risk of bias assessment | 11 | Specify the methods used to assess risk of bias in the included studies, including details of the tool(s) used, how many reviewers assessed each study and whether they worked independently, and if applicable, details of automation tools used in the process. | 8 |
Effect measures | 12 | Specify for each outcome the effect measure(s) (e.g., risk ratio, mean difference) used in the synthesis or presentation of results. | 8 |
Synthesis methods | 13a | Describe the processes used to decide which studies were eligible for each synthesis (e.g., tabulating the study intervention characteristics and comparing against the planned groups for each synthesis (item #5)). | 10–11 |
13b | Describe any methods required to prepare the data for presentation or synthesis, such as handling of missing summary statistics, or data conversions. | 8 | |
13c | Describe any methods used to tabulate or visually display results of individual studies and syntheses. | 8 | |
13d | Describe any methods used to synthesize results and provide a rationale for the choice(s). If meta-analysis was performed, describe the model(s), method(s) to identify the presence and extent of statistical heterogeneity, and software package(s) used. | 9 | |
13e | Describe any methods used to explore possible causes of heterogeneity among study results (e.g., subgroup analysis, meta-regression). | 9 | |
13f | Describe any sensitivity analyses conducted to assess robustness of the synthesized results. | NA | |
Reporting bias assessment | 14 | Describe any methods used to assess risk of bias due to missing results in a synthesis (arising from reporting biases). | 8 |
Certainty assessment | 15 | Describe any methods used to assess certainty (or confidence) in the body of evidence for an outcome. | NA |
RESULTS | |||
Study selection | 16a | Describe the results of the search and selection process, from the number of records identified in the search to the number of studies included in the review, ideally using a flow diagram. | 27 (Figure 1) |
16b | Cite studies that might appear to meet the inclusion criteria, but which were excluded, and explain why they were excluded. | 7 | |
Study characteristics | 17 | Cite each included study and present its characteristics. | 9–11 |
Risk of bias in studies | 18 | Present assessments of risk of bias for each included study. | 29–41 (Table 2) |
Results of individual studies | 19 | For all outcomes, present, for each study: (a) summary statistics for each group (where appropriate) and (b) an effect estimate and its precision (e.g., confidence/credible interval), ideally using structured tables or plots. | 42–65 (Table 3) |
Results of syntheses | 20a | For each synthesis, briefly summarize the characteristics and risk of bias among contributing studies. | 9–14 |
20b | Present results of all statistical syntheses conducted. If meta-analysis was performed, present for each the summary estimate and its precision (e.g., confidence/credible interval) and measures of statistical heterogeneity. If comparing groups, describe the direction of the effect. | NA | |
20c | Present results of all investigations of possible causes of heterogeneity among study results. | NA | |
20d | Present results of all sensitivity analyses conducted to assess the robustness of the synthesized results. | NA | |
Reporting biases | 21 | Present assessments of risk of bias due to missing results (arising from reporting biases) for each synthesis assessed. | NA |
Certainty of evidence | 22 | Present assessments of certainty (or confidence) in the body of evidence for each outcome assessed. | NA |
DISCUSSION | |||
Discussion | 23a | Provide a general interpretation of the results in the context of other evidence. | 15–18 |
23b | Discuss any limitations of the evidence included in the review. | 16–17 | |
23c | Discuss any limitations of the review processes used. | 17 | |
23d | Discuss implications of the results for practice, policy, and future research. | 18 | |
OTHER INFORMATION | |||
Registration and protocol | 24a | Provide registration information for the review, including register name and registration number, or state that the review was not registered. | 6 |
24b | Indicate where the review protocol can be accessed, or state that a protocol was not prepared. | 6 | |
24c | Describe and explain any amendments to information provided at registration or in the protocol. | 6 (OSF preregistration link) | |
Support | 25 | Describe sources of financial or non-financial support for the review, and the role of the funders or sponsors in the review. | 2 |
Competing interests | 26 | Declare any competing interests of review authors. | 1 |
Availability of data, code and other materials | 27 | Report which of the following are publicly available and where they can be found: template data collection forms; data extracted from included studies; data used for all analyses; analytic code; any other materials used in the review. | 2, 6, 8 |
Appendix A.3. Summary of Multilevel Interventions with Notable BP Outcomes and Population-Specific Effects
Study (First Author, Year) | Intervention Levels | Population Highlights | BP Outcome | Sustained Effects? | Notable Moderators/Subgroups |
Ard, 2017 [83] | Individual and Community Environment | Black women aged 30–70 | ↓ SBP and DBP in both groups (significant within-group reductions) | Not reported | Not reported |
Boulware, 2020 [27] | Individual and Healthcare Team | Black adults with uncontrolled hypertension | ↓ SBP among all groups (no intervention effect) | No (not sustained beyond intervention) | Not reported |
Crist, 2022 [32] | Individual and Healthcare Team and Health Policies | Adults aged 50+ who walk without assistance; senior/community centers serving low-income populations | ↓ SBP (significant at 18 months); ↑ cost-effectiveness | No (not sustained at 24 months) | Not reported |
Katon, 2010, 2012 [51,52] | Individual and Healthcare Team | Participants with diagnosis of diabetes and/or coronary heart disease | ↓ SBP (significant) | No (Not sustained at 18- or 24-month follow-up) | Not reported |
Petersen, 2013 [103] | Healthcare Team and Health Policies | Physicians who see adult patients in hospital-based settings | ↑ BP control (via provider incentives) | Mixed (effect of individual-level incentives not sustained after 18-month washout) | Not reported |
Svarstad, 2013 [76] | Individual and Healthcare Team and Health Policies | Black adults, 576 participants across 28 chain pharmacies | ↓ SBP (significant); ↑ BP control; ↑ adherence | Partial (SBP and adherence sustained at 12 months, but not BP control) | Not reported |
Victor, 2018, 2019 [108,109] | Individual and Healthcare Team and Community | Black men, barbershop-based | ↓ SBP and DBP (significant) | Yes (12-month maintenance) | Greater effect among men with SBP ≥ 140 mmHg referred to hypertension specialists |
References
- Dorans, K.S.; Mills, K.T.; He, J. Trends in prevalence and control of hypertension according to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline. J. Am. Heart Assoc. 2018, 7, e008888. [Google Scholar] [CrossRef] [PubMed]
- Carey, R.M.; Moran, A.E.; Whelton, P.K. Treatment of hypertension: A review. J. Am. Med. Assoc. 2022, 328, 1849–1861. [Google Scholar] [CrossRef]
- Rimando, M. Perceived barriers to and facilitators of hypertension management among underserved African American older adults. Ethn. Dis. 2015, 25, 329–336. [Google Scholar] [CrossRef]
- Pettey, C.M.; McSweeney, J.C.; Stewart, K.E.; Cleves, M.A.; Price, E.T.; Heo, S.; Souder, E. African Americans’ perceptions of adherence to medications and lifestyle changes prescribed to treat hypertension. SAGE Open 2016, 6, 2158244015623595. [Google Scholar] [CrossRef]
- Sallis, J.F.; Owen, N.; Fisher, E.B. Ecological models of health behavior. In Health Behavior and Health Education: Theory, Research, and Practice; Glanz, K., Rimer, B.K., Viswanath, K., Eds.; Jossey-Bass: San Francisco, CA, USA, 2008; pp. 465–486. [Google Scholar]
- Paskett, E.; Thompson, B.; Ammerman, A.S.; Ortega, A.N.; Marsteller, J.; Richardson, D. Multilevel interventions to address health disparities show promise in improving population health. Health Aff. 2016, 35, 1429–1434. [Google Scholar] [CrossRef]
- Powell-Wiley, T.M.; Baumer, Y.; Baah, F.O.; Baez, A.S.; Farmer, N.; Mahlobo, C.T.; Pita, M.A.; Potharaju, K.A.; Tamura, K.; Wallen, G.R. Social determinants of cardiovascular disease. Circ. Res. 2022, 130, 782–799. [Google Scholar] [CrossRef] [PubMed]
- Havranek, E.P.; Mujahid, M.S.; Barr, D.A.; Blair, I.V.; Cohen, M.S.; Cruz-Flores, S.; Davey-Smith, G.; Dennison-Himmelfarb, C.R.; Lauer, M.S.; Lockwood, D.W.; et al. Social determinants of risk and outcomes for cardiovascular disease: A scientific statement from the American Heart Association. Circulation 2015, 132, 873–898. [Google Scholar] [CrossRef] [PubMed]
- Braveman, P.; Gottlieb, L. The social determinants of health: It’s time to consider the causes of the causes. Public Health Rep. 2014, 129, 19–31. [Google Scholar] [CrossRef]
- Williams, D.R.; Costa, M.V.; Odumlani, A.O.; Mohammed, S.A. Moving upstream: How interventions that address the social determinants of health can improve health and reduce disparities. J. Public Health Manag. Pract. 2008, 14, S8–S17. [Google Scholar] [CrossRef]
- Benjamin, E.J.; Muntner, P.; Alonso, A.; Bittencourt, M.S.; Callaway, C.W.; Carson, A.P.; Chamberlain, A.M.; Chang, A.R.; Cheng, S.; Das, S.R.; et al. Heart disease and stroke statistics—2019 update: A report from the American Heart Association. Circulation 2019, 139, e56–e528. [Google Scholar] [CrossRef]
- Moise, N.; Cené, C.W.; Tabak, R.G.; Young, D.R.; Mills, K.T.; Essien, U.R.; Anderson, C.A.M.; Lopez-Jimenez, F. Leveraging implementation science for cardiovascular health equity: A scientific statement from the American Heart Association. Circulation 2022, 146, e260–e278. [Google Scholar] [CrossRef]
- Grant, M.J.; Booth, A. A typology of reviews: An analysis of 14 review types and associated methodologies. Health Inf. Libr. J. 2009, 26, 91–108. [Google Scholar] [CrossRef]
- Moher, D.; Liberati, A.; Tetzlaff, J.; Altmann, D.G. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009, 6, e1000097. [Google Scholar] [CrossRef]
- Sterne, J.A.C.; Savović, J.; Page, M.J.; Elbers, R.G.; Blencowe, N.S.; Boutron, I.; Cates, C.J.; Cheng, H.Y.; Corbett, M.S.; Eldridge, S.M.; et al. RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ 2019, 366, 14898. [Google Scholar] [CrossRef] [PubMed]
- Lloyd-Jones, D.M.; Allen, N.B.; Anderson, C.A.M.; Black, T.; Brewer, L.C.; Foraker, R.E.; Grandner, M.A.; Lavretsky, H.; Perak, A.M.; Sharma, G.; et al. Life’s Essential 8: Updating and enhancing the American Heart Association’s construct of cardiovascular health: A presidential advisory from the American Heart Association. Circulation 2022, 146, e18–e43. [Google Scholar] [CrossRef] [PubMed]
- McLeroy, K.R.; Bibeau, D.; Steckler, A.; Glanz, K. An ecological perspective on health promotion programs. Health Educ. Q. 1988, 15, 351–377. [Google Scholar] [CrossRef]
- Fisher, E.B.; Brownson, C.A.; O’Toole, M.L.; Shetty, G.; Anwuri, V.V.; Glasgow, R.E. Ecological approaches to self-management: The case of diabetes. Am. J. Health Promot. 2005, 95, 1523–1535. [Google Scholar] [CrossRef]
- Adair, R.; Wholey, D.R.; Christianson, J.; White, K.M.; Britt, H.; Lee, S. Improving chronic disease care by adding laypersons to the primary care team: A parallel randomized trial. Ann. Intern. Med. 2013, 159, 176–184. [Google Scholar] [CrossRef]
- Allen, J.K.; Dennison-Himmelfarb, C.R.; Szanton, S.L.; Bone, L.; Hill, M.N.; Levine, D.M.; West, M.; Barlow, A.; Lewis-Boyer, L.; Donnelly-Strozzo, M.; et al. Community Outreach and Cardiovascular Health (COACH) Trial: A randomized, controlled trial of nurse practitioner/community health worker cardiovascular disease risk reduction in urban community health centers. Circ. Cardiovasc. Qual. Outcomes 2011, 4, 595–602. [Google Scholar] [CrossRef] [PubMed]
- Anderegg, M.D.; Gums, T.H.; Uribe, L.; MacLaughlin, E.J.; Hoehns, J.; Bazaldua, O.V.; Ives, T.J.; Hahn, D.L.; Coffey, C.S.; Carter, B.L. Pharmacist intervention for blood pressure control in patients with diabetes and/or chronic kidney disease. Pharmacotherapy 2018, 38, 309–318. [Google Scholar] [CrossRef]
- Bogden, P.E.; Abbott, R.D.; Williamson, P.; Onopa, J.K.; Koontz, L.M. Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension. J. Gen. Intern. Med. 1998, 13, 740–745. [Google Scholar] [CrossRef] [PubMed]
- Bogner, H.R.; de Vries, H.F. Integration of depression and hypertension treatment: A pilot, randomized controlled trial. Ann. Fam. Med. 2008, 6, 295–301. [Google Scholar] [CrossRef] [PubMed]
- Bogner, H.R.; de Vries, H.F.; Kaye, E.M.; Morales, K.H. Pilot trial of a licensed practical nurse intervention for hypertension and depression. Fam. Med. 2013, 45, 323–329. [Google Scholar] [PubMed]
- Bosworth, H.B.; Olsen, M.K.; Dudley, T.; Orr, M.; Goldstein, M.K.; Datta, S.K.; McCant, F.; Gentry, P.; Simel, D.L.; Oddone, E.Z. Patient education and provider decision support to control blood pressure in primary care: A cluster randomized trial. Am. Heart J. 2009, 157, 450–456. [Google Scholar] [CrossRef]
- Bosworth, H.B.; Olsen, M.K.; McCant, F.; Stechuchak, K.M.; Danus, S.; Crowley, M.J.; Goldstein, K.M.; Zullig, L.L.; Oddone, E.Z. Telemedicine cardiovascular risk reduction in veterans: The CITIES trial. Am. Heart J. 2018, 199, 122–129. [Google Scholar] [CrossRef]
- Boulware, L.E.; Ephraim, P.L.; Hill-Briggs, F.; Roter, D.L.; Bone, L.R.; Wolff, J.L.; Lewis-Boyer, L.P.; Levine, D.M.; Greer, R.C.; Crews, D.C.; et al. Hypertension self-management in socially disadvantaged African Americans: The Achieving Blood Pressure Control Together (ACT) randomized comparative effectiveness trial. J. Gen. Intern. Med. 2020, 35, 142–152. [Google Scholar] [CrossRef]
- Carrasquillo, O.; Lebron, C.; Alonzo, Y.; Li, H.; Chang, A.; Kenya, S. Effect of a community health worker intervention among Latinos with poorly controlled type 2 diabetes. JAMA Intern. Med. 2017, 177, 948–954. [Google Scholar] [CrossRef]
- Cheng, E.M.; Cunningham, W.E.; Towfighi, A.; Sanossian, N.; Bryg, R.J.; Anderson, T.L.; Barry, F.; Douglas, S.M.; Hudson, L.; Ayala-Rivera, M.; et al. Efficacy of a chronic care-based intervention on secondary stroke prevention among vulnerable stroke survivors: A randomized controlled trial. Circ. Cardiovasc. Qual. Outcomes 2018, 11, e003228. [Google Scholar] [CrossRef]
- Chwastiak, L.A.; Luongo, M.; Russo, J.; Johnson, L.; Lowe, J.M.; Hoffman, G.; McDonell, M.G.; Wisse, B. Use of a mental health center collaborative care team to improve diabetes care and outcomes for patients with psychosis. Psychiatr. Serv. 2018, 69, 349–352. [Google Scholar] [CrossRef]
- Cooper, L.A.; Roter, D.L.; Carson, K.A.; Bone, L.R.; Larson, S.M.; Miller, E.R., 3rd; Barr, M.S.; Levine, D.M. A randomized trial to improve patient-centered care and hypertension control in underserved primary care patients. J. Gen. Intern. Med. 2011, 26, 1297–1304. [Google Scholar] [CrossRef]
- Crist, K.; Full, K.M.; Linke, S.; Tuz-Zahra, F.; Bolling, K.; Lewars, B.; Liu, C.; Shi, Y.; Rosenberg, D.; Jankowska, M.; et al. Health effects and cost-effectiveness of a multilevel physical activity intervention in low-income older adults: Results from the PEP4PA cluster randomized controlled trial. Int. J. Behav. Nutr. Phys. Act. 2022, 19, 75. [Google Scholar] [CrossRef] [PubMed]
- Crowley, M.J.; Powers, B.J.; Olsen, M.K.; Grubber, J.M.; Koropchak, C.; Rose, C.M.; Gentry, P.; Bowlby, L.; Trujillo, G.; Maciejewski, M.L.; et al. The Cholesterol, Hypertension, And Glucose Education (CHANGE) study: Results from a randomized controlled trial in African Americans with diabetes. Am. Heart J. 2013, 166, 179–186. [Google Scholar] [CrossRef]
- Crowley, M.J.; Edelman, D.; McAndrew, A.T.; Kistler, S.; Danus, S.; Webb, J.A.; Zanga, J.; Sanders, L.L.; Coffman, C.J.; Jackson, G.L.; et al. Practical telemedicine for veterans with persistently poor diabetes control: A randomized pilot trial. Telemed. J. E-Health 2016, 22, 376–384. [Google Scholar] [CrossRef] [PubMed]
- Daumit, G.L.; Dalcin, A.T.; Dickerson, F.B.; Miller, E.R.; Evins, A.E.; Cather, C.; Jerome, G.J.; Young, D.R.; Charleston, J.B.; Gennusa, J.V., 3rd; et al. Effect of a comprehensive cardiovascular risk reduction intervention in persons with serious mental illness: A randomized clinical trial. JAMA Netw. Open 2020, 3, e207247. [Google Scholar] [CrossRef]
- De La Rosa, M.; Pitts, S.; Chen, P.H. An interprofessional collaboration of care to improve clinical outcomes for patients with diabetes. J. Interprof. Care 2020, 34, 269–271. [Google Scholar] [CrossRef]
- Dennison, C.R.; Post, W.S.; Kim, M.T.; Bone, L.R.; Cohen, D.; Blumenthal, R.S.; Rame, J.E.; Roary, M.C.; Levine, D.M.; Hill, M.N. Underserved urban African American men: Hypertension trial outcomes and mortality during 5 years. Am. J. Hypertens. 2007, 20, 164–171. [Google Scholar] [CrossRef]
- Hill, M.N.; Han, H.R.; Dennison, C.R.; Kim, M.T.; Roary, M.C.; Blumenthal, R.S.; Bone, L.R.; Levine, D.M.; Post, W.S. Hypertension care and control in underserved urban African American men: Behavioral and physiologic outcomes at 36 months. Am. J. Hypertens. 2003, 16, 906–913. [Google Scholar] [CrossRef] [PubMed]
- Emery-Tiburcio, E.E.; Rothschild, S.K.; Avery, E.F.; Wang, Y.; Mack, L.; Golden, R.L.; Holmgreen, L.; Hobfoll, S.; Richardson, D.; Powell, L.H. BRIGHTEN Heart intervention for depression in minority older adults: Randomized controlled trial. Health Psychol. 2019, 38, 1–11. [Google Scholar] [CrossRef]
- Feldman, P.H.; McDonald, M.V.; Barrón, Y.; Gerber, L.M.; Peng, T.R. Home-based interventions for Black patients with uncontrolled hypertension: A cluster randomized controlled trial. J. Comp. Eff. Res. 2016, 5, 155–168. [Google Scholar] [CrossRef]
- Gabbay, R.A.; Lendel, I.; Saleem, T.M.; Shaeffer, G.; Adelman, A.M.; Mauger, D.T.; Collins, M.; Polomano, R.C. Nurse case management improves blood pressure, emotional distress and diabetes complication screening. Diabetes Res. Clin. Pract. 2006, 71, 28–35. [Google Scholar] [CrossRef]
- Gabbay, R.A.; Añel-Tiangco, R.M.; Dellasega, C.; Mauger, D.T.; Adelman, A.; Van Horn, D.H. Diabetes nurse case management and motivational interviewing for change (DYNAMIC): Results of a 2-year randomized controlled pragmatic trial. J. Diabetes 2013, 5, 349–357. [Google Scholar] [CrossRef] [PubMed]
- Gary, T.L.; Bone, L.R.; Hill, M.N.; Levine, D.M.; McGuire, M.; Saudek, C.; Brancati, F.L. Randomized controlled trial of the effects of nurse case manager and community health worker interventions on risk factors for diabetes-related complications in urban African Americans. Prev. Med. 2003, 37, 23–32. [Google Scholar] [CrossRef] [PubMed]
- Green, B.B.; Anderson, M.L.; Cook, A.J.; Catz, S.; Fishman, P.A.; McClure, J.B.; Reid, R.J. e-Care for heart wellness: A feasibility trial to decrease blood pressure and cardiovascular risk. Am. J. Prev. Med. 2014, 46, 368–377. [Google Scholar] [CrossRef] [PubMed]
- Heisler, M.; Hofer, T.P.; Schmittdiel, J.A.; Selby, J.V.; Klamerus, M.L.; Bosworth, H.B.; Bermann, M.; Kerr, E.A. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: The adherence and intensification of medications cluster randomized, controlled pragmatic trial. Circulation 2012, 125, 2863–2872. [Google Scholar] [CrossRef]
- Hennessy, S.; Leonard, C.E.; Yang, W.; Kimmel, S.E.; Townsend, R.R.; Wasserstein, A.G.; Ten Have, T.R.; Bilker, W.B. Effectiveness of a two-part educational intervention to improve hypertension control: A cluster-randomized trial. Pharmacotherapy 2006, 26, 1342–1347. [Google Scholar] [CrossRef]
- Hiss, R.G.; Armbruster, B.A.; Gillard, M.L.; McClure, L.A. Nurse care manager collaboration with community-based physicians providing diabetes care: A randomized controlled trial. Diabetes Educ. 2007, 33, 493–502. [Google Scholar] [CrossRef]
- Hunt, J.S.; Siemienczuk, J.; Pape, G.; Rozenfeld, Y.; MacKay, J.; LeBlanc, B.H.; Touchette, D. A randomized controlled trial of team-based care: Impact of physician-pharmacist collaboration on uncontrolled hypertension. J. Gen. Intern. Med. 2008, 23, 1966–1972. [Google Scholar] [CrossRef]
- Islam, N.S.; Wyatt, L.C.; Ali, S.H.; Zanowiak, J.M.; Mohaimin, S.; Goldfeld, K.; Lopez, P.; Kumar, R.; Beane, S.; Thorpe, L.E.; et al. Integrating community health workers into community-based primary care practice settings to improve blood pressure control among South Asian immigrants in New York City: Results from a randomized control trial. Circ. Cardiovasc. Qual. Outcomes 2023, 16, e009321. [Google Scholar] [CrossRef]
- Kangovi, S.; Mitra, N.; Grande, D.; Huo, H.; Smith, R.A.; Long, J.A. Community health worker support for disadvantaged patients with multiple chronic diseases: A randomized clinical trial. Am. J. Public Health 2017, 107, 1660–1667. [Google Scholar] [CrossRef]
- Katon, W.J.; Lin, E.H.B.; Korff, M.V.; Ciechanowski, P.; Ludman, E.J.; Young, B.; Peterson, D.; Rutter, C.M.; McGregor, M.; McCulloch, D. Collaborative care for patients with depression and chronic illnesses. N. Engl. J. Med. 2010, 363, 2611–2620. [Google Scholar] [CrossRef]
- Katon, W.; Russo, J.; Lin, E.H.; Schmittdiel, J.; Ciechanowski, P.; Ludman, E.; Peterson, D.; Young, B.; Von Korff, M. Cost-effectiveness of a multicondition collaborative care intervention: A randomized controlled trial. Arch. Gen. Psychiatry 2012, 69, 506–514. [Google Scholar] [CrossRef] [PubMed]
- Kilbourne, A.M.; Goodrich, D.E.; Lai, Z.; Post, E.P.; Schumacher, K.; Nord, K.M.; Bramlet, M.; Chermack, S.; Bialy, D.; Bauer, M.S. Randomized controlled trial to assess reduction of cardiovascular disease risk in patients with bipolar disorder: The Self-Management Addressing Heart Risk Trial (SMAHRT). J. Clin. Psychiatry 2013, 74, e655–e662. [Google Scholar] [CrossRef] [PubMed]
- Krein, S.L.; Klamerus, M.L.; Vijan, S.; Lee, J.L.; Fitzgerald, J.T.; Pawlow, A.; Reeves, P.; Hayward, R.A. Case management for patients with poorly controlled diabetes: A randomized trial. Am. J. Med. 2004, 116, 732–739. [Google Scholar] [CrossRef]
- Lin, E.H.; Von Korff, M.; Peterson, D.; Ludman, E.J.; Ciechanowski, P.; Katon, W. Population targeting and durability of multimorbidity collaborative care management. Am. J. Manag. Care 2014, 20, 887–895. [Google Scholar]
- Ma, J.; Berra, K.; Haskell, W.L.; Klieman, L.; Hyde, S.; Smith, M.W.; Xiao, L.; Stafford, R.S. Case management to reduce cardiovascular risk in a county healthcare system. Arch. Intern. Med. 2009, 169, 1988–1995. [Google Scholar] [CrossRef]
- Margolis, K.L.; Asche, S.E.; Dehmer, S.P.; Bergdall, A.R.; Green, B.B.; Sperl-Hillen, J.M.; Nyboer, R.A.; Pawloski, P.A.; Maciosek, M.V.; Trower, N.K.; et al. Long-term outcomes of the effects of home blood pressure telemonitoring and pharmacist management on blood pressure among adults with uncontrolled hypertension: Follow-up of a cluster randomized clinical trial. JAMA Netw. Open 2018, 1, e181617. [Google Scholar] [CrossRef]
- Margolis, K.L.; Bergdall, A.R.; Crain, A.L.; Jaka, M.M.; Anderson, J.P.; Solberg, L.I.; Sperl-Hillen, J.; Beran, M.; Green, B.B.; Haugen, P.; et al. Comparing pharmacist-led telehealth care and clinic-based care for uncontrolled high blood pressure: The Hyperlink 3 pragmatic cluster-randomized trial. Hypertension 2022, 79, 2708–2720. [Google Scholar] [CrossRef] [PubMed]
- McClintock, H.F.; Bogner, H.R. Incorporating patients’ social determinants of health into hypertension and depression care: A pilot randomized controlled trial. Community Ment. Health J. 2017, 53, 703–710. [Google Scholar] [CrossRef]
- Nguyen-Huynh, M.N.; Young, J.D.; Ovbiagele, B.; Alexander, J.G.; Alexeeff, S.; Lee, C.; Blick, N.; Caan, B.J.; Go, A.S.; Sidney, S. Effect of lifestyle coaching or enhanced pharmacotherapy on blood pressure control among Black adults with persistent uncontrolled hypertension: A cluster randomized clinical trial. JAMA Netw. Open 2022, 5, e2212397. [Google Scholar] [CrossRef]
- Planas, L.G.; Crosby, K.M.; Farmer, K.C.; Harrison, D.L. Evaluation of a diabetes management program using selected HEDIS measures. J. Am. Pharm. Assoc. 2012, 52, e130–e138. [Google Scholar] [CrossRef]
- Prezio, E.A.; Cheng, D.; Balasubramanian, B.A.; Shuval, K.; Kendzor, D.E.; Culica, D. Community Diabetes Education (CoDE) for uninsured Mexican Americans: A randomized controlled trial of a culturally tailored diabetes education and management program led by a community health worker. Diabetes Res. Clin. Pract. 2013, 100, 19–28. [Google Scholar] [CrossRef] [PubMed]
- Rosas, L.G.; Thiyagarajan, S.; Goldstein, B.A.; Drieling, R.L.; Romero, P.P.; Ma, J.; Yank, V.; Stafford, R.S. The effectiveness of two community-based weight loss strategies among obese, low-income US Latinos. J. Acad. Nutr. Diet. 2015, 115, 537–550.e532. [Google Scholar] [CrossRef]
- Scott, D.M.; Boyd, S.T.; Stephan, M.; Augustine, S.C.; Reardon, T.P. Outcomes of pharmacist-managed diabetes care services in a community health center. Am. J. Health-Syst. Pharm. 2006, 63, 2116–2122. [Google Scholar] [CrossRef]
- Vaughan, E.M.; Johnston, C.A.; Cardenas, V.J.; Moreno, J.P.; Foreyt, J.P. Integrating CHWs as part of the team leading diabetes group visits: A randomized controlled feasibility study. Diabetes Educ. 2017, 43, 589–599. [Google Scholar] [CrossRef]
- Von Korff, M.; Katon, W.J.; Lin, E.H.; Ciechanowski, P.; Peterson, D.; Ludman, E.J.; Young, B.; Rutter, C.M. Functional outcomes of multi-condition collaborative care and successful ageing: Results of randomised trial. BMJ 2011, 343, d6612. [Google Scholar] [CrossRef]
- Zillich, A.J.; Sutherland, J.M.; Kumbera, P.A.; Carter, B.L. Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study). J. Gen. Intern. Med. 2005, 20, 1091–1096. [Google Scholar] [CrossRef] [PubMed]
- Holtrop, J.S.; Luo, Z.; Piatt, G.; Green, L.A.; Chen, Q.; Piette, J. Diabetic and obese patient clinical outcomes improve during a care management implementation in primary care. J. Prim. Care Community Health 2017, 8, 312–318. [Google Scholar] [CrossRef] [PubMed]
- Huebschmann, A.G.; Mizrahi, T.; Soenksen, A.; Beaty, B.L.; Denberg, T.D. Reducing clinical inertia in hypertension treatment: A pragmatic randomized controlled trial. J. Clin. Hypertens. 2012, 14, 322–329. [Google Scholar] [CrossRef]
- Murray, M.D.; Harris, L.E.; Overhage, J.M.; Zhou, X.H.; Eckert, G.J.; Smith, F.E.; Buchanan, N.N.; Wolinsky, F.D.; McDonald, C.J.; Tierney, W.M. Failure of computerized treatment suggestions to improve health outcomes of outpatients with uncomplicated hypertension: Results of a randomized controlled trial. Pharmacotherapy 2004, 24, 324–337. [Google Scholar] [CrossRef]
- Piatt, G.A.; Anderson, R.M.; Brooks, M.M.; Songer, T.; Siminerio, L.M.; Korytkowski, M.M.; Zgibor, J.C. 3-year follow-up of clinical and behavioral improvements following a multifaceted diabetes care intervention: Results of a randomized controlled trial. Diabetes Educ. 2010, 36, 301–309. [Google Scholar] [CrossRef]
- Ralston, J.D.; Hirsch, I.B.; Hoath, J.; Mullen, M.; Cheadle, A.; Goldberg, H.I. Web-based collaborative care for type 2 diabetes: A pilot randomized trial. Diabetes Care 2009, 32, 234–239. [Google Scholar] [CrossRef]
- Rothman, R.L.; Malone, R.; Bryant, B.; Shintani, A.K.; Crigler, B.; Dewalt, D.A.; Dittus, R.S.; Weinberger, M.; Pignone, M.P. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am. J. Med. 2005, 118, 276–284. [Google Scholar] [CrossRef] [PubMed]
- Roumie, C.L.; Elasy, T.A.; Greevy, R.; Griffin, M.R.; Liu, X.; Stone, W.J.; Wallston, K.A.; Dittus, R.S.; Alvarez, V.; Cobb, J.; et al. Improving blood pressure control through provider education, provider alerts, and patient education: A cluster randomized trial. Ann. Intern. Med. 2006, 145, 165–175. [Google Scholar] [CrossRef] [PubMed]
- Schoenthaler, A.; de la Calle, F.; Pitaro, M.; Lum, A.; Chaplin, W.; Mogavero, J.; Rosal, M.C. A systems-level approach to improving medication adherence in hypertensive Latinos: A randomized controlled trial. J. Gen. Intern. Med. 2020, 35, 182–189. [Google Scholar] [CrossRef]
- Svarstad, B.L.; Kotchen, J.M.; Shireman, T.I.; Brown, R.L.; Crawford, S.Y.; Mount, J.K.; Palmer, P.A.; Vivian, E.M.; Wilson, D.A. Improving refill adherence and hypertension control in Black patients: Wisconsin TEAM trial. J. Am. Pharm. Assoc. 2013, 53, 520–529. [Google Scholar] [CrossRef] [PubMed]
- Svetkey, L.P.; Pollak, K.I.; Yancy, W.S., Jr.; Dolor, R.J.; Batch, B.C.; Samsa, G.; Matchar, D.B.; Lin, P.H. Hypertension improvement project: Randomized trial of quality improvement for physicians and lifestyle modification for patients. Hypertension 2009, 54, 1226–1233. [Google Scholar] [CrossRef]
- Talavera, G.A.; Castañeda, S.F.; Mendoza, P.M.; Lopez-Gurrola, M.; Roesch, S.; Pichardo, M.S.; Garcia, M.L.; Muñoz, F.; Gallo, L.C. Latinos understanding the need for adherence in diabetes (LUNA-D): A randomized controlled trial of an integrated team-based care intervention among Latinos with diabetes. Transl. Behav. Med. 2021, 11, 1665–1675. [Google Scholar] [CrossRef]
- Towfighi, A.; Cheng, E.M.; Ayala-Rivera, M.; Barry, F.; McCreath, H.; Ganz, D.A.; Lee, M.L.; Sanossian, N.; Mehta, B.; Dutta, T.; et al. Effect of a coordinated community and chronic care model team intervention vs usual care on systolic blood pressure in patients with stroke or transient ischemic attack. JAMA Netw. Open 2021, 4, e2036227. [Google Scholar] [CrossRef] [PubMed]
- Vinicor, F.; Cohen, S.J.; Mazzuca, S.A.; Moorman, N.; Wheeler, M.; Kuebler, T.; Swanson, S.; Ours, P.; Fineberg, S.E.; Gordon, E.E. DIABEDS: A randomized trial of the effects of physician and/or patient education on diabetes patient outcomes. J. Chronic Dis. 1987, 40, 345–356. [Google Scholar] [CrossRef]
- Wang, V.; Smith, V.A.; Bosworth, H.B.; Oddone, E.Z.; Olsen, M.K.; McCant, F.; Powers, B.J.; Van Houtven, C.H. Economic evaluation of telephone self-management interventions for blood pressure control. Am. Heart J. 2012, 163, 980–986. [Google Scholar] [CrossRef]
- Welch, G.; Allen, N.A.; Zagarins, S.E.; Stamp, K.D.; Bursell, S.E.; Kedziora, R.J. Comprehensive diabetes management program for poorly controlled Hispanic type 2 patients at a community health center. Diabetes Educ. 2011, 37, 680–688. [Google Scholar] [CrossRef] [PubMed]
- Ard, J.D.; Carson, T.L.; Shikany, J.M.; Li, Y.; Hardy, C.M.; Robinson, J.C.; Williams, A.G.; Baskin, M.L. Weight loss and improved metabolic outcomes amongst rural African American women in the Deep South: Six-month outcomes from a community-based randomized trial. J. Intern. Med. 2017, 282, 102–113. [Google Scholar] [CrossRef]
- Brewer, L.C.; Jenkins, S.; Hayes, S.N.; Kumbamu, A.; Jones, C.; Burke, L.E.; Cooper, L.A.; Patten, C.A. Community-based, cluster-randomized pilot trial of a cardiovascular mobile health intervention: Preliminary findings of the FAITH! trial. Circulation 2022, 146, 175–190. [Google Scholar] [CrossRef]
- Brown, D.L.; Conley, K.M.; Sánchez, B.N.; Resnicow, K.; Cowdery, J.E.; Sais, E.; Murphy, J.; Skolarus, L.E.; Lisabeth, L.D.; Morgenstern, L.B. A multicomponent behavioral intervention to reduce stroke risk factor behaviors: The stroke health and risk education cluster-randomized controlled trial. Stroke 2015, 46, 2861–2867. [Google Scholar] [CrossRef]
- Derose, K.P.; Williams, M.V.; Flórez, K.R.; Griffin, B.A.; Payán, D.D.; Seelam, R.; Branch, C.A.; Hawes-Dawson, J.; Mata, M.A.; Whitley, M.D.; et al. Eat, Pray, Move: A pilot cluster randomized controlled trial of a multilevel church-based intervention to address obesity among African Americans and Latinos. Am. J. Health Promot. 2019, 33, 586–596. [Google Scholar] [CrossRef]
- Kerr, J.; Rosenberg, D.; Millstein, R.A.; Bolling, K.; Crist, K.; Takemoto, M.; Godbole, S.; Moran, K.; Natarajan, L.; Castro-Sweet, C.; et al. Cluster randomized controlled trial of a multilevel physical activity intervention for older adults. Int. J. Behav. Nutr. Phys. Act. 2018, 15, 32. [Google Scholar] [CrossRef] [PubMed]
- Nafziger, A.N.; Erb, T.A.; Jenkins, P.L.; Lewis, C.; Pearson, T.A. The Otsego-Schoharie healthy heart program: Prevention of cardiovascular disease in the rural US. Scand. J. Public Health Suppl. 2001, 56, 21–32. [Google Scholar] [CrossRef] [PubMed]
- Paskett, E.D.; Baltic, R.D.; Syoung, G.; Katz, M.L.; Lesko, S.M.; Hwebber, K.; Roberto, K.A.; Lengerich, E.J.; Schoenberg, N.E.; Kennedy, S.K.; et al. A group randomized trial to reduce obesity among Appalachian church members: The Walk by Faith study. Cancer Epidemiol. Biomark. Prev. 2018, 27, 1289–1297. [Google Scholar] [CrossRef]
- Seguin, R.A.; Paul, L.; Folta, S.C.; Nelson, M.E.; Strogatz, D.; Graham, M.L.; Diffenderfer, A.; Eldridge, G.; Parry, S.A. Strong Hearts, Healthy Communities: A community-based randomized trial for rural women. Obesity 2018, 26, 845–853. [Google Scholar] [CrossRef]
- Seguin-Fowler, R.A.; Strogatz, D.; Graham, M.L.; Eldridge, G.D.; Marshall, G.A.; Folta, S.C.; Pullyblank, K.; Nelson, M.E.; Paul, L. The Strong Hearts, Healthy Communities Program 2.0: An RCT examining effects on Simple 7. Am. J. Prev. Med. 2020, 59, 32–40. [Google Scholar] [CrossRef]
- Baranowski, T.; Simons-Morton, B.; Hooks, P.; Henske, J.; Tiernan, K.; Dunn, J.K.; Burkhalter, H.; Harper, J.; Palmer, J. A center-based program for exercise change among Black-American families. Health Educ. Q. 1990, 17, 179–196. [Google Scholar] [CrossRef] [PubMed]
- Matthan, N.R.; Barger, K.; Wylie-Rosett, J.; Xue, X.; Groisman-Perelstein, A.E.; Diamantis, P.M.; Ginsberg, M.; Mossavar-Rahmani, Y.; Lichtenstein, A.H. Spillover effects of a family-based childhood weight-management intervention on parental nutrient biomarkers and cardiometabolic risk factors. Curr. Dev. Nutr. 2022, 6, nzab152. [Google Scholar] [CrossRef] [PubMed]
- Rosland, A.M.; Piette, J.D.; Trivedi, R.; Lee, A.; Stoll, S.; Youk, A.O.; Obrosky, D.S.; Deverts, D.; Kerr, E.A.; Heisler, M. Effectiveness of a health coaching intervention for patient-family dyads to improve outcomes among adults with diabetes: A randomized clinical trial. JAMA Netw. Open 2022, 5, e2237960. [Google Scholar] [CrossRef]
- Trief, P.M.; Fisher, L.; Sandberg, J.; Cibula, D.A.; Dimmock, J.; Hessler, D.M.; Forken, P.; Weinstock, R.S. Health and psychosocial outcomes of a telephonic couples behavior change intervention in patients with poorly controlled type 2 diabetes: A randomized clinical trial. Diabetes Care 2016, 39, 2165–2173. [Google Scholar] [CrossRef]
- Trief, P.M.; Fisher, L.; Sandberg, J.; Hessler, D.M.; Cibula, D.A.; Weinstock, R.S. Two for one? Effects of a couples intervention on partners of persons with Type 2 diabetes: A randomized controlled trial. Diabet. Med. 2019, 36, 473–481. [Google Scholar] [CrossRef]
- Wieland, M.L.; Hanza, M.M.M.; Weis, J.A.; Meiers, S.J.; Patten, C.A.; Clark, M.M.; Sloan, J.A.; Novotny, P.J.; Njeru, J.W.; Abbenyi, A.; et al. Healthy Immigrant Families: Randomized controlled trial of a family-based nutrition and physical activity intervention. Am. J. Health Promot. 2018, 32, 473–484. [Google Scholar] [CrossRef] [PubMed]
- Yates, B.C.; Rowland, S.; Mancuso, K.; Kupzyk, K.A.; Norman, J.F.; Shurmur, S.; Tesina, K. Reducing cardiovascular risk in spouses of cardiac patients: A randomized controlled trial. West. J. Nurs. Res. 2015, 37, 85–102. [Google Scholar] [CrossRef]
- Haskell, W.L.; Berra, K.; Arias, E.; Christopherson, D.; Clark, A.; George, J.; Hyde, S.; Klieman, L.; Myll, J. Multifactor cardiovascular disease risk reduction in medically underserved, high-risk patients. Am. J. Cardiol. 2006, 98, 1472–1479. [Google Scholar] [CrossRef]
- Levine, D.M.; Bone, L.R.; Hill, M.N.; Stallings, R.; Gelber, A.C.; Barker, A.; Harris, E.C.; Zeger, S.L.; Felix-Aaron, K.L.; Clark, J.M. The effectiveness of a community/academic health center partnership in decreasing the level of blood pressure in an urban African-American population. Ethn. Dis. 2003, 13, 354–361. [Google Scholar]
- Pearce, K.A.; Love, M.M.; Shelton, B.J.; Schoenberg, N.E.; Williamson, M.A.; Barron, M.A.; Houlihan, J.M. Cardiovascular risk education and social support (CaRESS): Report of a randomized controlled trial from the Kentucky Ambulatory Network (KAN). J. Am. Board. Fam. Med. 2008, 21, 269–281. [Google Scholar] [CrossRef]
- Pérez-Escamilla, R.; Damio, G.; Chhabra, J.; Fernandez, M.L.; Segura-Pérez, S.; Vega-López, S.; Kollannor-Samuel, G.; Calle, M.; Shebl, F.M.; D’Agostino, D. Impact of a community health workers-led structured program on blood glucose control among Latinos with type 2 diabetes: The DIALBEST trial. Diabetes Care 2015, 38, 197–205. [Google Scholar] [CrossRef] [PubMed]
- Petersen, L.A.; Simpson, K.; Pietz, K.; Urech, T.H.; Hysong, S.J.; Profit, J.; Conrad, D.A.; Dudley, R.A.; Woodard, L.D. Effects of individual physician-level and practice-level financial incentives on hypertension care: A randomized trial. J. Am. Med. Assoc. 2013, 310, 1042–1050. [Google Scholar] [CrossRef]
- Peterson, K.A.; Radosevich, D.M.; O’Connor, P.J.; Nyman, J.A.; Prineas, R.J.; Smith, S.A.; Arneson, T.J.; Corbett, V.A.; Weinhandl, J.C.; Lange, C.J.; et al. Improving diabetes care in practice: Findings from the TRANSLATE trial. Diabetes Care 2008, 31, 2238–2243. [Google Scholar] [CrossRef]
- Weber, C.A.; Ernst, M.E.; Sezate, G.S.; Zheng, S.; Carter, B.L. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch. Intern. Med. 2010, 170, 1634–1639. [Google Scholar] [CrossRef] [PubMed]
- Victor, R.G.; Ravenell, J.E.; Freeman, A.; Leonard, D.; Bhat, D.G.; Shafiq, M.; Knowles, P.; Storm, J.S.; Adhikari, E.; Bibbins-Domingo, K.; et al. Effectiveness of a barber-based intervention for improving hypertension control in black men: The BARBER-1 study: A cluster randomized trial. Arch. Intern. Med. 2011, 171, 342–350. [Google Scholar] [CrossRef]
- Rader, F.; Elashoff, R.M.; Niknezhad, S.; Victor, R.G. Differential treatment of hypertension by primary care providers and hypertension specialists in a barber-based intervention trial to control hypertension in Black men. Am. J. Cardiol. 2013, 112, 1421–1426. [Google Scholar] [CrossRef] [PubMed]
- Victor, R.G.; Lynch, K.; Li, N.; Blyler, C.; Muhammad, E.; Handler, J.; Brettler, J.; Rashid, M.; Hsu, B.; Foxx-Drew, D.; et al. A cluster-randomized trial of blood-pressure reduction in Black barbershops. N. Engl. J. Med. 2018, 378, 1291–1301. [Google Scholar] [CrossRef]
- Victor, R.G.; Blyler, C.A.; Li, N.; Lynch, K.; Moy, N.B.; Rashid, M.; Chang, L.C.; Handler, J.; Brettler, J.; Rader, F.; et al. Sustainability of blood pressure reduction in Black barbershops. Circulation 2019, 139, 10–19. [Google Scholar] [CrossRef]
- Pereira, M.A.; Mullane, S.L.; Toledo, M.J.L.; Larouche, M.L.; Rydell, S.A.; Vuong, B.; Feltes, L.H.; Mitchell, N.R.; de Brito, J.N.; Hasanaj, K.; et al. Efficacy of the ‘Stand and Move at Work’ multicomponent workplace intervention to reduce sedentary time and improve cardiometabolic risk: A group randomized clinical trial. Int. J. Behav. Nutr. Phys. Act. 2020, 17, 133. [Google Scholar] [CrossRef]
- Wilcox, S.; Parrott, A.; Baruth, M.; Laken, M.; Condrasky, M.; Saunders, R.; Dowda, M.; Evans, R.; Addy, C.; Warren, T.Y.; et al. The Faith, Activity, and Nutrition program: A randomized controlled trial in African-American churches. Am. J. Prev. Med. 2013, 44, 122–131. [Google Scholar] [CrossRef]
- Skolarus, L.E.; Dinh, M.; Kidwell, K.M.; Lin, C.C.; Buis, L.R.; Brown, D.L.; Oteng, R.; Giacalone, M.; Warden, K.; Trimble, D.E.; et al. Reach Out Emergency Department: A a randomized factorial trial to determine the optimal mobile health components to reduce blood pressure. Circ. Cardiovasc. Qual. Outcomes 2023, 16, e009606. [Google Scholar] [CrossRef] [PubMed]
- Campbell, F.; Conti, G.; Heckman, J.J.; Moon, S.H.; Pinto, R.; Pungello, E.; Pan, Y. Early childhood investments substantially boost adult health. Science 2014, 343, 1478–1485. [Google Scholar] [CrossRef]
- Chobanian, A.V.; Bakris, G.L.; Black, H.R.; Cushman, W.C.; Green, L.A.; Izzo, J.L.; Jones, D.W.; Materson, B.J.; Oparil, S.; Wright, J.T., Jr.; et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC-7 Report. J. Am. Med. Assoc. 2003, 289, 2560–2571. [Google Scholar] [CrossRef] [PubMed]
- Ostchega, Y.; Fryar, C.D.; Nwankwo, T.; Nguyen, D.T. Hypertension prevalence among adults aged 18 and over: United States, 2017–2018. In NCHS Data Brief; Homepage for the National Center for Health Statistics: Hyattsville, MD, USA, 2020; Volume 364. [Google Scholar]
- Muntner, P.; Hardy, S.T.; Fine, L.J.; Jaeger, B.C.; Wozniak, G.; Levitan, E.B.; Colantonio, L.D. Trends in blood pressure control among US adults with hypertension, 1999–2000 to 2017–2018. J. Oft. He Am. Med. Assoc. 2020, 324, 1190–1200. [Google Scholar] [CrossRef]
- McGill, R.; Anwar, E.; Orton, L.; Bromley, H.; Lloyd-Williams, F.; O’Flaherty, M.; Taylor-Robinson, D.; Guzman-Castillo, M.; Gillespie, D.; Moreira, P.; et al. Are interventions to promote healthy eating equally effective for all? Systematic review of socioeconomic inequalities in impact. BMC Public Health 2015, 15, 457. [Google Scholar] [CrossRef]
- Egan, B.M.; Li, J.; Sutherland, S.E.; Jones, D.W.; Ferdinand, K.C.; Hong, Y.; Sanchez, E. Sociodemographic determinants of Life’s Simple 7: Implications for achieving cardiovascular health and health equity goals. Ethn. Dis. 2020, 30, 637–650. [Google Scholar] [CrossRef]
- Zhou, Y.; Dai, X.; Ni, Y.; Zeng, Q.; Cheng, Y.; Carrillo-Larco, R.; Yan, L.L.; Xu, X. Interventions and management on multimorbidity: An overview of systematic reviews. Ageing Res. Rev. 2023, 87, 101901. [Google Scholar] [CrossRef] [PubMed]
- Samanic, C.M.; Barbour, K.E.; Liu, Y.; Wang, Y.; Fang, J.; Lu, H.; Schieb, L.; Greenlund, K.J. Prevalence of self-reported hypertension and antihypertensive medication use by county and rural-urban classification—United States, 2017. MMWR Morb. Mortal. Wkly. Rep. 2020, 69, 533–539. [Google Scholar] [CrossRef]
- Zha, P.; Qureshi, R.; Porter, S.; Chao, Y.-Y.; Pacquiao, D.; Chase, S.; O’Brien-Richardson, P. Using a mobile health intervention to manage hypertension in an underserved community. West. J. Nurs. Res. 2020, 42, 201–209. [Google Scholar] [CrossRef]
- Ebinger, J.; Blyler, C.A.; Brettler, J.; Rader, F. Barbershop management of hypertension in the African American population: Pitfalls and opportunities for extension to other underserved communities. Curr. Cardiol. Rep. 2020, 22, 64. [Google Scholar] [CrossRef]
- Harrington, R.A.; Califf, R.M.; Balamurugan, A.; Brown, N.; Benjamin, R.M.; Braund, W.E.; Hipp, J.; Konig, M.; Sanchez, E.; Maddox, K.E.J. Call to action: Rural health: A presidential advisory from the American Heart Association and American Stroke Association. Circulation 2020, 141, e615–e644. [Google Scholar] [CrossRef] [PubMed]
- Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021, 327, n71. [Google Scholar] [CrossRef] [PubMed]
Inclusion Criteria | |
---|---|
Population | -Community-dwelling adults 18+ (e.g., not in long-term nursing) -Study conducted in the United States -Participants can come from cohort studies or among community-dwelling patient populations (e.g., adults with hypertension) |
Interventions | -Multilevel interventions (any that target at least 2 levels, such as individuals and their healthcare providers) with reported results -Individual or cluster-randomized trial Multilevel: Policies, social interventions, or care teams that involve multiple people or systems. Most unilevel interventions tend to target the patient, e.g., disease self-management or psychoeducation alone or are cultural adaptations of patient-only interventions (e.g., physical activity intervention) |
Comparison | Active control; no-contact control; wait-list control; treatment as usual |
Outcomes | -Blood pressure (primary) -Hypertension (prevalence; risk; secondary outcomes to be reported if enough studies meet criteria) -Note: Results could include raw scores in mmHg, classification into hypertension categories, or as part of risk calculators like Life’s Essential 8 or its predecessor, Life’s Simple 7 |
Article-Specific Criteria | -Any publication date -Articles published in English -Published in peer-reviewed journals (i.e., not grey literature) |
First Author (Year) | Sample Size and Major Demographic Characteristics | Major Inclusion Criteria | Risk of Bias Score |
---|---|---|---|
Individual and Healthcare Team | |||
Adair (2013) [19] | 2135 participants across 6 clinics -9.5% non-Caucasian -48.5% men -Baseline systolic BP: 128.8 mmHg -Baseline diastolic BP: 74.4 mmHg | Adults aged 18–79 years with hypertension, diabetes, or congestive heart failure | Some Concerns |
Allen (2011) [20] | 525 participants -79.4% Black/African American -28.8% men Baseline systolic BP: 139.2 mmHg Baseline diastolic BP: 82.7 mmHg | Black/African American or White adults aged 21+ Diagnosed cardiovascular disease | Low |
Anderegg (2018) [21] | 335 participants across 32 medical offices in 15 states -62% non-Caucasian -36% men -Baseline systolic BP: 147.18 mmHg -Baseline diastolic BP: 81.26 mmHg | English- or Spanish-speaking adults 18+ with diagnosed hypertension Uncontrolled hypertension (≥140/90 or ≥130/80 with type 2 diabetes or chronic kidney disease) | Low |
Bogden (1998) [22] | 95 participants -25% mixed Hawaiian -42% men -Baseline systolic BP: 155.5 mmHg -Baseline diastolic BP: 95.5 mmHg | Uncontrolled hypertension (≥140/90 with target organ damage and CVD risk factors OR ≥ 150/95 without target organ damage/CVD risk factors) on 3 consecutive clinic visits in the previous 6 months | Low |
Bogner (2008) [23] | 64 participants -82.8% Black/African American -23% men -Baseline systolic BP: 144.9 mmHg -Baseline diastolic BP: 82.2 mmHg | Aged 50+ Presence of elevated BP and a diagnosis of depression or antidepressant prescription within past year | Some Concerns |
Bogner (2013) [24] | 60 participants -38.3% Black/African American -35% men -Baseline systolic BP: 136.5 mmHg -Baseline diastolic BP: 76.4 mmHg | Aged 40+ Presence of elevated BP and a diagnosis of depression or antidepressant prescription within past year | Low |
Bosworth (2009) [25] | 32 primary care providers and 588 patients -40% Black/African American -98% men -Baseline systolic BP: 140 mmHg -Baseline diastolic BP: 76 mmHg | Patients enrolled at Veterans Affairs Medical Center Diagnosis of hypertension by outpatient diagnostic code and had filled prescription for hypertensive medication in past year | Low |
Bosworth (2018) [26] | 428 participants -50% Black/African American -84.8% men -Baseline systolic BP: 130.1 mmHg -Baseline diastolic BP: 75.8 mmHg | Aged 40+ Had diagnosis of hypertension or hypercholesterolemia Poorly controlled hypertension in past year | Low |
Boulware (2020) [27] | -159 participants -100% Black/African American -26.4% men -Baseline (median) systolic BP: 137 mmHg -Baseline (median) diastolic BP: 80 mmHg | English-speaking adults aged 18+ Self-reported Black/African American race Uncontrolled hypertension as evidenced by clinic records | Low |
Carrasquillo (2017) [28] | 300 participants -100% Hispanic/Latinx -45% men -Baseline systolic BP: 133 mmHg -Diastolic BP not reported | Hispanic/Latinx adults aged 18–65 HbA1c levels of 8.0 or greater | Some Concerns |
Cheng (2018) [29] | 404 participants -60% men -14.6% non-Hispanic/Latinx Black/African American -68% Hispanic/Latinx -Baseline systolic BP: 149.9 Diastolic BP not reported | Participant had TIA or ischemic stroke within the past 90 days and systolic BP > 120 mm/Hg | Low |
Chwastiak (2018) [30] | 35 adults -66% men -60% non-White -Baseline systolic BP: 134.9 mmHg -Diastolic BP not reported | Participants with psychosis HbA1c levels of 8.0 or greater Presence of diabetes | Low |
Cooper (2011) [31] | 41 primary care physicians and 279 patients Physician Demographics -46% men -29% Black/African American Patient Demographics -34% men -62% Black/African American -Baseline systolic BP: 135.2 mmHg -Baseline diastolic BP: 75.6 mmHg | General internists and family physicians who saw patients at least 20 h/week Patients were aged 18+ and had a diagnosis of hypertension | Some Concerns |
Crist (2022) [32] | 476 participants across 12 senior or community centers -24.3% men -62.4% Black/African American -Baseline systolic BP: 129.7 mmHg -Baseline diastolic BP: 71.9 mmHg | Senior/community centers that primarily served low-income populations and offer at least 1 physical activity class Participants had to be at least 50 years old and able to walk without human assistance | Low |
Crowley (2013) [33] | 359 adults across 2 clinics -28% men -100% Black/African American -Baseline systolic BP: 136.8 mmHg -Diastolic BP not reported | Black/African American adults aged 18+ with type 2 diabetes | Low |
Crowley (2016) [34] | 50 participants -96% men -54% Black/African American -Baseline systolic BP: 127 mmHg -Baseline diastolic BP: 80 mmHg | Veteran with type 2 diabetes and HbA1c levels of 9.0 or greater for >year | Some Concerns |
Daumit (2020) [35] | 269 participants -47.6% men -46% Black/African American -Baseline systolic BP: 119.5 mmHg -Baseline diastolic BP: 75.1 mmHg | Adults aged 18+ with hypertension, diabetes, dyslipidemia, current tobacco smoking, and/or overweight/obese Participants received care from outpatient psychiatric rehab program | Low |
De La Rosa (2020) [36] | 6 nursing student case managers and 58 participants -Gender and race not reported -Baseline systolic BP: 135 mmHg -Baseline diastolic BP: 82 mmHg | Patients with diabetes | Some Concerns |
Dennison (2007) [37] Hill (2003) [38]: 36-month outcomes | 309 adults -100% men -100% Black/African American -Baseline systolic BP: 147.5 mmHg -Baseline diastolic BP: 99 mmHg | Black/African American men between 21 and 54 years old and had hypertension | Some Concerns |
Emery-Tiburcio (2019) [39] | 250 participants -50% Black/African American -50% Hispanic/Latinx -19.6% men -Baseline systolic BP: 140.6 mmHg -Baseline diastolic BP: 77.2 mmHg | Self-identified Black/African American adults aged 60+ BMI > 25.0 and symptoms of depression as evinced by Patient Health Questionnaire-9 scores ≥ 8 | Low |
Feldman (2016) [40] | 845 participants and 312 nurses -100% Black/African American -34% men -Baseline systolic BP: 155.5 mmHg -Baseline diastolic BP: 87.3 mmHg | Black/African American adults with uncontrolled hypertension | Some Concerns |
Gabbay (2006) [41] | 332 participants -No race reported -55% men -Baseline systolic BP: 136.5 mmHg -Baseline diastolic BP: 77 mmHg | Participants with diabetes and aged 18+ | Low |
Gabbay (2013) [42] | 545 participants -46.5% non-White -38.7% Hispanic/Latinx -41.8% men -Baseline systolic BP: 143.5 mmHg -Baseline diastolic BP: 79 mmHg | Participants aged between 18 and 75 with type 2 diabetes and had one of the following: (1) HbA1c levels ≥ 8.5%; (2) BP > 140/90 mmHg; or (3) LDL > 130 | Some Concerns |
Gary (2003) [43] | 186 participants -100% Black/African American -24% men -Baseline systolic BP: 127 mmHg -Baseline diastolic BP: 76 mmHg | Black/African American adults aged between 35–75 Presence of type 2 diabetes | Low |
Green (2014) [44] | 101 participants -5% Black/African American -58% men -Baseline systolic BP: 150.4 mmHg -Baseline diastolic BP: 91.6 mmHg | Adults aged 30–69 years old with BMI > 26, elevated BP, and 10–25% 10-year Framingham CVD risk | Some Concerns |
Heisler (2012) [45] | 4100 participants across 16 primary care teams at 5 medical centers -70% men -15% Black/African American -10% Hispanic/Latinx -Systolic BP from last 3 months: 156.5 mmHg -Diastolic BP from last 3 months: 79 mmHg | Patients with diabetes Evidence of persistent poor BP control, poor medication refill adherence, or insufficient medication intensification | Low |
Hennessy (2006) [46] | 10,698 participants across 93 providers -43.1% men -41% Black/African American -53% with baseline BP < 140/90 mmHg | Physicians and nurse practitioners in family medicine, internal medicine, and obstetrics-gynecology who cared for at least 10 eligible participants Participants had a diagnosis of hypertension (ICD-9 codes of 401.x or 402.x) | Some Concerns |
Hiss (2007) [47] | 197 participants -33% men -27% Black/African American -Baseline systolic BP: 131.2 mmHg -Baseline diastolic BP: 73.9 mmHg | Adult participants with type 2 diabetes | Some Concerns |
Hunt (2008) [48] | 463 participants -35% men -Race not reported -Baseline systolic BP: 173.5 mmHg -Baseline diastolic BP: 91 mmHg | Participants with known hypertension and uncontrolled BP Participants who have received care at study practice | Low |
Islam (2023) [49] | 303 participants -49.5% men -100% South Asian -Baseline systolic BP: 138.2 mmHg -Baseline diastolic BP: 86.4 mmHg | Self-reported South Asian ancestry from India, Bangladesh, Pakistan, Nepal, Sri Lanka, or the Indo-Caribbean Aged between 18 and 85 Diagnosis of hypertension and/or uncontrolled BP within the past 6 months | Low |
Kangovi (2017) [50] | 302 participants -24.5% men -95% Black/African American -Baseline systolic BP: 143.8 mmHg -No diastolic BP reported | Participants living in a high-poverty region of Philadelphia Presence of 2 or more following chronic diseases: hypertension, diabetes, obesity, tobacco dependence | Low |
Katon (2010) [51] Katon (2012) [52] | 214 participants -48% men -47% non-White or Hispanic/Latinx -Baseline systolic BP: 134 -No diastolic BP reported | Participants with diagnosis of diabetes, coronary heart disease, or both Patents had one or more measure of poor disease control within past 112 months | Low Low |
Kilbourne (2013) [53] | 116 participants -83% men -5% non-White -Baseline systolic BP: 132.8 mmHg -Baseline diastolic BP: 82.2 mmHg | IDC-9 diagnosis of bipolar disorder ≥1 cardiovascular disease risk factor | Some Concerns |
Krein (2004) [54] | 246 participants -97% men -41.7% non-White -Baseline systolic BP: 145 mmHg -Baseline diastolic BP: 86 mmHg | Adults aged 18+ who were diagnosed with type 2 diabetes and had HbA1c levels ≥ 7.5% | Low |
Lin (2014) [55] | 214 adults -52% men -No race reported -Baseline systolic BP range: 93.5–195.5 mmHg -No diastolic BP reported | Participants with depression and uncontrolled diabetes and/or coronary heart disease | Low |
Ma (2009) [56] | 419 adults -34.4% men -9.6% Black/African American -63% Hispanic/Latinx -Baseline systolic BP: 133.9 mmHg -Baseline diastolic BP: 79.6 mmHg | Adults between 35 and 85 years old who had moderately to-severely elevated levels of major modifiable cardiovascular disease risk factors | Low |
Margolis (2018) [57] | 450 participants across 16 clinics -55% men -12% Black/African American -Baseline systolic BP: 148 mmHg -Baseline diastolic BP: 84.7 mmHg | Individuals with a BP of 140/90 mmHg or high at 2 most recent primary care encounters in the last year Uncontrolled BP obtained from 3 measures in a research clinic | Low |
Margolis (2022) [58] | 3071 participants across 21 primary care clinics -47% men -19% Black/African American -Baseline systolic BP: 158.0 mmHg -Baseline diastolic BP: 91.7 mmHg | Participants aged between 18 and 85 years who had an encounter with one of the study clinic sites during the enrollment period and had a hypertension diagnosis code within the past 24 months | Some Concerns |
McClintock (2017) [59] | 54 participants from 3 primary care clinics -26% men -59% Black/African American -Baseline systolic BP: 134.3 mmHg -Baseline diastolic BP: 75.25 mmHg | Participants aged 18+ with a diagnosis of hypertension and a current prescription for an antihypertensive | Some Concerns |
Nguyen-Huynh (2022) [60] | 1761 participants -31% men -100% Black/African American -Baseline systolic BP: 150.5 mmHg -Baseline diastolic BP: 84.5 mmHg | Self-reported Black/African American adults aged 18+ who were listed in a hypertension registry | Some Concerns |
Planas (2012) [61] | 65 participants -41% men -15% Black/African American -Baseline systolic BP: 140.1 mmHg -Baseline diastolic BP: 76.7 mmHg | Adults aged 18+ and had a most recent recording of HbA1c levels of 7.0% or greater | Some Concerns |
Prezio (2013) [62] | 180 participants -39% men -81.7% Hispanic/Latinx -11.7% Black/African American -Baseline systolic BP: 126 mmHg -Baseline diastolic BP: 79 mmHg | Active clinic patients between the ages of 18–85 years old and diagnosed with type 2 diabetes | Low |
Rosas (2015) [63] | 207 participants -76.8% men -100% Hispanic/Latinx -Baseline systolic BP: 115.2 mmHg -Baseline diastolic BP: 73.6 mmHg | Spanish-speaking Hispanic/Latinx adults BMI between 30 and 60 and one or coronary heart disease risk factors | Low |
Scott (2006) [64] | 149 participants -38.9% men -3.4% Black/African American -32.2% Hispanic/Latinx -Baseline systolic BP: 130.5 mmHg -Baseline diastolic BP: 79.4 mmHg | Adults aged 18+ with a diagnosis of type 2 diabetes | High |
Vaughan (2017) [65] | 50 participants Gender not reported -100% Hispanic/Latinx -Baseline systolic BP: 133.5 mmHg -Baseline diastolic BP: 81.6 mmHg | Hispanic/Latinx adults aged 18+ with a documented diagnosis of type 2 diabetes or prediabetes | Some Concerns |
Von Korff (2011) [66] | 214 participants across 14 care clinics -48% men -23% non-White -Baseline systolic BP: 134 mmHg -Diastolic BP not reported | Participants with diabetes and/or coronary heart disease; evidence of poor BP, cholesterol, or glycemic control | Low |
Zillich (2005) [67] | 125 participants across 12 community pharmacies -2% non-White -39.2% men -Baseline systolic BP: 151.5 mmHg -Baseline diastolic BP: 85.3 mmHg | Participants were aged 21+ with a diagnosis of hypertension, took 1–3 BP medications with no recent changes (past 4 weeks), and had uncontrolled BP | Low |
Individual and Healthcare Team and Health Policies | |||
Holtrop (2017) [68] | 1392 participants across 10 practices -53.8% men -Race not reported -Baseline systolic BP: 127.3 mmHg -No diastolic BP reported | Adults aged 18+ receiving care at one of the study practices A diagnosis of type 2 diabetes or obesity (BMI ≥ 30) | Some Concerns |
Huebschmann (2012) [69] | 591 participants -45.4% men -23.2% Black/African American -Baseline systolic BP: 149 mmHg -Baseline diastolic BP: 90.5 mmHg | Participants aged 18–79 years with elevated BP based on 2 or 3 most recent clinic visits | Some Concerns |
Murray (2004) [70] | 712 participants -56% men -33% Black/African American -Baseline systolic BP: 143 mmHg -Baseline diastolic BP: 76.75 mmHg | Participants had an active outpatient diagnosis of hypertension or (1) at least 2 systolic BP measurements of 140 mmHg or greater, (2) 2 diastolic BP measurements of 90 mmHg or greater, and (3) a prescription for at least one antihypertensive medication | Some Concerns |
Piatt (2010) [71] | 119 participants across 11 primary care practices -50% men -8% non-White -Baseline systolic BP: 141.1 mmHg -Baseline diastolic BP: 74.6 mmHg | Participants with diagnosis of type 2 diabetes receiving care from one of the study sites | Some Concerns |
Ralston (2009) [72] | 83 participants -51.6% men -18.7% non-White -Baseline systolic BP: 133 mmHg -Baseline diastolic BP: 76 mmHg | Adults aged between 18 and 75 and had a most recent recording of HbA1c levels of 7.0% or greater in the past 12 months | Low |
Rothman (2005) [73] | 217 participants -64% Black/African American -44% men -Baseline systolic BP: 138.5 mmHg -Baseline diastolic BP: 81 mmHg | Adults aged 18+ with a clinical diagnosis of type 2 diabetes Those with poor glycemic control (HbA1c levels of 8.0% or more) | Low |
Roumie (2006) [74] | 1341 participants across 182 providers -Race and gender not reported -Baseline systolic BP: 157.2 mmHg -Baseline diastolic BP: 82.7 mmHg | Adults aged between 21 and 90 years, filled their medications at Veterans Administration pharmacies, were only taking 1 antihypertensive medication, and had at least 2 uncontrolled BP measures in 6-month baseline period. | Some Concerns |
Schoenthaler (2020) [75] | 119 participants -50.4% men -100% Hispanic/Latinx -Baseline systolic BP: 141.7 mmHg -Baseline diastolic BP:81.2 mmHg | Self-identified Hispanic/Latinx adults aged 18+ with uncontrolled hypertension, taking at least 1 antihypertensive medication and were nonadherent, and had at least 1 comorbid diagnosis | Low |
Svarstad (2013) [76] | 576 participants across 28 chain pharmacies -33.9% men -100% Black/African American -Baseline systolic BP: 152.2 mmHg -Baseline diastolic BP: 92.5 mmHg | Patients were eligible if they were Black/African American adults aged 18+, had an active antihypertensive medication filled at the study pharmacy, and presence of elevated BP | Low |
Svetkey (2009) [77] | 574 participants and 32 physicians -39% men -37% Black/African American -Baseline systolic BP: 133.1 mmHg -Baseline diastolic BP: 74.1 mmHg | Patients were eligible if they were 25+ and had hypertension based on billing codes | Low |
Talavera (2021) [78] | 456 participants -36.3% men -100% Hispanic/Latinx -Baseline systolic BP: 128 mmHg -Baseline diastolic BP: 74.6 mmHg | Self-identified Hispanic/Latinx adults aged 18+ with physician diagnosis of type 2 diabetes and no current insulin use | Low |
Towfighi (2021) [79] | 487 participants -65.1% men -18.3% Black/African American -71.3% Hispanic/Latinx -Baseline systolic BP: 144.4 mmHg -No diastolic BP reported | Adults aged 40+ who experienced ischemic, hemorrhagic stroke, or transient ischemic attack within the past 90 days; elevated systolic BP | Low |
Vinicor (1987) [80] | 509 participants -22% men -71.3% Black/African American -Baseline systolic BP: 140 mmHg -Baseline diastolic BP: 82.7 mmHg | Participants with type 2 diabetes | Some Concerns |
Wang (2012) [81] | 591 participants -92% men -48% Black/African American -Baseline systolic BP: 129 mmHg -Baseline diastolic BP: 77 mmHg | Inadequate BP control in year before enrolling in study trial | Low |
Welch (2011) [82] | 46 participants -35% men -100% Hispanic/Latinx Race not reported -Baseline systolic BP: 137.5 mmHg -Baseline diastolic BP: 80.5 mmHg | Adults aged between 30 and 85 years old Presence of type 2 diabetes for at least 1 year based on medical review and treatment history Hispanic/Latinx ethnicity HbA1c levels between 7.5–14% | Low |
Individual and Community Environment | |||
Ard (2017) [83] | 409 participants across 8 counties -100% Black/African American -0% men -Baseline systolic BP: 125.1 mmHg -Baseline diastolic BP: 79.5 mmHg | Self-identified Black/African American women aged between 30 and 70 years Overweight or obese (BMI ≥ 25 kg/m2) | Low |
Brewer (2022) [84] | 136 participants across 16 churches -100% Black/African American -29% men -Baseline systolic BP: 134.31 mmHg -Baseline diastolic BP: 81.38 mmHg | Churches with predominantly Black/African American parishioners | Low |
Brown (2015) [85] | 760 participants across 10 churches -83.7% Hispanic/Latinx -36.2% men -Baseline systolic BP: 125.5 mmHg -Baseline diastolic BP: 79.2 mmHg | Hispanic/Latinx or non-Hispanic/Latinx White adults aged 18+ Parishioner of participating parish | Some Concerns |
Derose (2019) [86] | 268 adults across 4 churches (Baptist and Catholic) -45.3% Black/African American -51.1% Hispanic/Latinx -25.4% men -Baseline systolic BP: 131.9 mmHg -Baseline diastolic BP: 76.2 mmHg | Adults aged 18+ who attend church at least monthly | Some Concerns |
Kerr (2018) [87] | 307 participants across 11 San Diego retirement communities -27% men -No race reported -Baseline systolic BP: 131.4 mmHg -Baseline diastolic BP: 68.1 mmHg | Adults aged 65+ Retirement communities with at least 100 residents, had independent living options, and had stores or parks within 1 mile | Low |
Nafziger (2001) [88] | 626 participants -44.6% men -1% non-White -Baseline systolic BP: 127.2 mmHg -Baseline diastolic BP: 78.0 mmHg | Adults aged between 20 and 69 years and lived in the study counties (rural New York) for at least 6 months of the year | Some Concerns |
Paskett (2018) [89] | 663 participants across 60 churches in 5 states -29.3% men -1.8% Black/African American -Baseline systolic BP: 135.9 mmHg -Baseline diastolic BP: 82.4 mmHg | Churches with >250 members in Appalachian counties interested in participating in the study Participants at least 18 years old and attended church at least 4 times in the past 2 months BMI of at least 25 | Low |
Seguin (2018) [90] | 194 participants -0% men -5% non-White -Baseline systolic BP: 134.4 mmHg -Baseline diastolic BP: 87.5 mmHg | Women aged 40+ with BMI ≥ 25 and sedentary or not meeting physical activity guidelines | Low |
Seguin-Fowler (2020) [91] | 182 participants -0% men -2.4% non-White -Baseline systolic BP: 132.6 mmHg -Baseline diastolic BP: 85.4 mmHg | Women aged 40+ with BMI between 25 and 30 and sedentary or not meeting physical activity guidelines | Low |
Individual and Family/Social Support | |||
Baranowski (1990) [92] | 94 Black/African American families -100% Black/African American -No baseline BP reported | Families with at least one self-reported Black/African American child between the 5th and 7th grade No diagnosed cardiovascular disease | Low |
Matthan (2022) [93] | 205 participants -6% men -17.4% Black/African American -74.8% Hispanic/Latinx -67% with normal BP (<120/80 mmHg) | Children between the ages of 7–12 years and BMI ≥ 85th percentile for age and sex | Low |
Rosland (2022) [94] | 239 participants and care partner dyads -96.7% men -12.6% Black/African American -Baseline systolic BP: 140.2 mmHg -Diastolic BP not reported | Adults aged between 30 and 70 years with type 2 diabetes Those with poor glycemic or BP control during past 9 months | Low |
Trief (2016) [95] Trief (2019) [96] | 268 participants -61.6% men -17.3% Black/African American -7.1% Hispanic/Latinx -Baseline systolic BP: 126.7 mmHg -Baseline diastolic BP: 74.4 mmHg 268 care partners -35.4% men -16.1% Black/African American -6.1% Hispanic/Latinx -Baseline systolic BP: 122.8 mmHg -Baseline diastolic BP: 73.8 mmHg | Patients were adults aged 21+ who had diagnosis of type 2 diabetes for >1 year and baseline HbA1c levels ≥ 7.5%; and in a self-defined committed relationship for ≥1 year | Low Low |
Wieland (2018) [97] | 151 participants (81 adolescents and 70 adults—adult values presented here) -28.6% men -39% Somali or Sudanese -61% Hispanic/Latinx -Baseline systolic BP: 122.1 mmHg -Baseline diastolic BP: 76.3 mmHg | Households with at least 1 adult and 1 adolescent aged 10–18 years | Low |
Yates (2015) [98] | 34 participants and their spouses/partners -14.8% men -6% Hispanic/Latinx -6% non-White -Baseline systolic BP: 126 mmHg -No diastolic BP reported | Participants aged 19+ who are the spouse/partner (>1 year) of someone who received coronary artery bypass surgery For these analyses, only the spouses/partners were included. | Low |
Individual and Family/Social Support and Healthcare Team | |||
Haskell (2006) [99] | 148 participants -7% Black/African American -57% Hispanic/Latinx -43.3% men -Baseline systolic BP: 141 mmHg -Baseline diastolic BP: 82 mmHg | Adults aged between 35 and 80 years old who had (1) limited or no health insurance and low family income, (2) increased risk of having a cardiac event, and (3) currently received medical care at nonprofit or free clinic/hospital | Low |
Levine (2003) [100] | 789 participants -38.15% men -100% Black/African American -Baseline systolic BP: 148.15 mmHg -Baseline diastolic BP: 89.2 mmHg | Black/African American adults aged 18+ with hypertension | Low |
Pearce (2008) [101] | 199 participants and 108 support persons across 18 practices -44.7% men -13.1% Black/African American -Baseline systolic BP: 140.3 mmHg -Baseline diastolic BP: 76.8 mmHg | Adults aged 21+ Participant had type 2 diabetes based on chart review, diagnosis, or a current prescription for antidiabetic drugs Hypertension with suboptimal control | Low |
Pérez-Escamilla (2015) [102] | 211 participants -26.5% men 100% Hispanic/Latinx -Baseline systolic BP: 119.5 mmHg -No diastolic BP reported | Self-identified Hispanic/Latinx adults aged 21+ with a documented diagnosis of type 2 diabetes for >12 months, had HbA1c levels of 7.0% or greater | Low |
Healthcare Team and Health Policies | |||
Petersen (2013) [103] | 77 physicians across 12 hospitals 56% men -7.7% Black/African American -80% of patients with controlled hypertension at baseline | Inclusion criteria not specified | Low |
Peterson (2008) [104] | 7101 participants across 24 practices -50% men -Race not reported -Baseline systolic BP: 132.75 mmHg -No diastolic BP reported | Major practice-level eligibility: (1) single-specialty community primary care, (2) availability of 24 months of billing data, (3) 3–22 full-time equivalent providers Major participant eligibility: Adults aged between 18 and 89 years old with type 2 diabetes | Low |
Weber (2010) [105] | 179 participants -43% men -9% non-White -Baseline systolic BP: 151.7 mmHg -Baseline diastolic BP: 85.1 mmHg | Adults aged between 21 and 85 years receive between 0 and 3 antihypertensive agents with no changes to their regimen within the past 4 weeks Clinic systolic BP between 145 and 179 mmHg or diastolic BP of 95–109 mmHg (without diabetes) Clinic systolic BP between 135 and 179 mmHg or diastolic BP of 85–109 mmHg (with diabetes) | Low |
Individual and Healthcare Team and Community Environment | |||
Victor (2011) [106] Rader (2013) [107] subgroup analysis | 1297 participants across 17 barbershops in Dallas County -100% men -100% Black/African American -Baseline systolic BP: 137 mmHg -Baseline diastolic BP: 80 mmHg 138 participants -100% men -100% Black/African American -Baseline systolic BP: 157 mmHg -Baseline diastolic BP: 90 mmHg | Barbershops had non-Hispanic/Latinx Black/African American owners and barbers, had been in business for 10+ years, had 3 or more barbers, >90% Black/African American men clientele Customers eligible for the intervention were self-reported non-Hispanic/Latinx Black/African American men aged 18+. (Rader) This was a subgroup analysis limited to those with baseline systolic BP ≥ 140 mmHg and 10-month follow-up data | Low Low |
Victor (2018) [108] Victor (2019) [109] | 319 participants across 52 barbershops in Los Angeles County -100% men -100% Black/African American -Baseline systolic BP: 153.7 mmHg -Baseline diastolic BP: 91 mmHg | Non-Hispanic/Latinx men aged between 35 and 79 years old with systolic BP of 140 mmHg | Low Low |
Individual and Community Environment and Health Policies | |||
Pereira (2020) [110] | 630 participants across 24 work sites -4.1% Black/African American -13.8% Hispanic/Latinx -Baseline systolic BP: 124.3 mmHg -Baseline diastolic BP: 77.5 mmHg | Full-time employees of study work site aged 18+, have generally good health, and willing to have a sit–stand workstation installed Worksites had 20–60 employees with predominantly seated desk-based office work who did not have a current worksite wellness program | Low |
Wilcox (2013) [111] | 1257 participants across 128 churches -24.3% men -99.4% Black/African American -Baseline systolic BP: 128.5 mmHg -Baseline diastolic BP: 70.6 mmHg | Participants aged 18+ who were free of serious medical conditions that would make physical activity or diet changes difficult Participants needed to attend church services at least 1 time/month | Low |
Individual and Health Policies | |||
Skolarus (2023) [112] | 488 participants -22.8% men -54% Black/African American -Baseline systolic BP: 146 mmHg -No diastolic BP reported | Participants with at least 1 documented systolic BP ≥ 160 mmHg or a diastolic BP ≥ 90 mmHg, likely to be discharged from the emergency department, and had text messaging capability | Some Concerns |
Individual and Family/Social Support and Healthcare Team and Community Environment | |||
Campbell (2014) [113] | 111 children from 109 families -47% men -96% Black/African American -No baseline BP reported | -Children born between 1972–1977 -High-Risk Index > 11 to indicate disadvantaged background | Some Concerns |
First Author (Year) Intervention Duration | Intervention Activities | Control Group | Summary of Results |
---|---|---|---|
Individual and Healthcare Team | |||
Adair (2013) [19] 12 months | Individual: Participate in individualized care plan activities Healthcare Team: Nonclinical care guide works with participant, physician to address care goals; submit quarterly reports to physician on goal progress and participant concerns | Usual care | Significantly more treatment goals were met in the intervention compared to the usual care group |
Allen (2011) [20] 12 months | Individual: Therapeutic lifestyle changes, including diet, exercise, and smoking cessation Healthcare Team: Nurse practitioner and community health worker teams for lifestyle counseling, medication titration/prescription, and communicate goals with physician | Enhanced usual care | Significant reductions compared to control group in systolic BP (6.2 mmHg) and diastolic BP (3.1 mmHg); Systolic BP reductions were clinically significant |
Anderegg (2018) [21] 9 months | Individual: Participate in individualized care plan activities Healthcare Team: Pharmacists co-developed individualized care plan for BP goal with participant; care plan was discussed and adjusted with physician input | Usual care | Significant reductions compared to control group in systolic BP (8.64 mmHg) and diastolic BP (2.90 mmHg) |
Bogden (1998) [22] 6 months | Individual: Participate in individualized care plan activities Healthcare Team: Pharmacists, physicians, and patients would coordinate a treatment regimen in shared medical appointments | Usual care | Significant decrease in systolic BP (14 mmHg) and diastolic BP (23 mmHg) in the intervention; BP changes were greater in intervention group Intervention effects unrelated to age, gender; effective for mixed-ancestry Hawaiians. |
Bogner (2008) [23] 4 weeks | Individual: Participate in individualized care plan activities Healthcare Team: Integrated care manager who provided patient with individualized hypertension and depression program; collaborated with physician to deliver care and monitor adherence | Usual care | Significantly greater decreases in posttest systolic BP and diastolic BP among intervention group (127.3 mmHg and 75.8 mmHg, respectively). |
Bogner (2013) [24] 12 weeks | Individual: Participate in individualized care plan activities Healthcare Team: Integrated Licensed Practical Nurses who provided patient with individualized hypertension and depression program; collaborated with physician to deliver care and monitor adherence | Usual care | Significantly greater decreases in posttest diastolic BP (74.2 mmHg) but not systolic BP (130 mmHg) among intervention relative to control group |
Bosworth (2009) [25] 24 months | Individual: Participate in individualized educational and behavioral intervention with nurse Healthcare Team: Computer-assisted medication decision support system for physicians; quarterly audit and feedback of entire patient panel regarding BP targets, medication choices | Usual care (clinical reminders); intervention was factorial design | No significant posttest differences in participants’ systolic BP by intervention group. |
Bosworth (2018) [26] 12 months | Individual: Participate in disease self-management activities; individualized educational and behavioral intervention Healthcare Team: Clinical pharmacist-led behavioral intervention for patients; coordinate with physician to adjust medication as needed | Education control group | Both groups had significantly decreased systolic BP over time; No significant posttest differences in participants’ systolic BP or diastolic BP by intervention group |
Boulware (2020) [27] 12 months | Individual: Participate in hypertension self-management activities; 9 weeks of problem-solving training Healthcare Team: Community health workers provided training to participants; address barriers to hypertension care (including resource linking); communicate with clinic nurses if BP was not under control | Usual care (single contact with community health workers to receive BP monitor) | Systolic and diastolic BP improved across time in all groups; there were no significant intervention effects |
Carrasquillo (2017) [28] 12 months | Individual: Participate in group psychoeducation and exercise activities Healthcare Team: Community Health Worker provided health education, patient navigation (including linking resources and serving as a liaison between patients, physicians), health coaching; assisted with nonmedical services (e.g., legal assistance, employment) | Usual care | Although there was a statistical reduction in systolic BP in multivariate models, reductions were lower than planned 8 mmHg The intervention significantly lowered systolic BP only among study completers who had a baseline systolic BP ≥ 140 mmHg |
Cheng (2018) [29] 12 months | Individual: Participate in disease self-management, lifestyle modification activities Healthcare Team: Disease case management with physician assistant or nurse practitioner (with computerized decision support); delivered interventions to participants, led care coordination between appts; coordinate medication adjustment with physician | Education and usual care control | There were significant reductions in systolic BP in both groups across time, but there were no significant intervention effects (p = 0.55) |
Chwastiak (2018) [30] 3 months | Individual: Participate in disease self-management, lifestyle modification activities Healthcare Team: Weekly systematic caseload review with collaborative care team, including nurse care managers, psychiatrists, registered nurses, and endocrinologists | Usual care | There were no significant changes in systolic BP across time, regardless of group assignment |
Cooper (2011) [31] 12 months | Individual: Communication coaching delivered by community health workers Healthcare Team: Physicians communication skills program training and feedback | Usual care (factorial design) | There were no significant changes in systolic or diastolic BP by intervention group Among those with uncontrolled BP at baseline, there were larger but nonsignificant changes among all interventions compared to patient and physician minimal group |
Crist (2022) [32] 24 months | Individual: Participate in physical activity goal setting, self-monitoring activities Healthcare Team: Peer health coaches led group walking; organized activities in community (e.g., “community advocacy to improve walking conditions”) | Usual care | There were significant reductions among the intervention group for systolic BP and diastolic BP at 18 months, but there were no other between-group differences. This was not sustained at 24 months. |
Crowley (2013) [33] 12 months | Individual: Diabetes self-management activities Healthcare Team: Nurse-supported disease self-management support; medication management facilitation between the patient and physician | Usual care | There were no between-group differences at posttest for systolic BP (p = 0.11) |
Crowley (2016) [34] 6 months | Individual: Diabetes self-management activities Healthcare Team: Nurse-supported disease self-management support; medication management facilitation between the patient and physician; Physician-guided depression management | Usual care | The intervention group had significantly decreased systolic BP (p = 0.035) and diastolic BP (p = 0.013) compared to control group at posttest |
Daumit (2020) [35] 18 months | Individual: Participating in individualized risk reduction education and counseling activities Healthcare Team: Health coach and nurse-delivered education and counseling; collaboration with physicians, mental health staff for treatment and arranging follow-up appointments | Usual care | There were no significant effects of the intervention on systolic or diastolic BP |
De La Rosa (2020) [36] 12 months | Individual: Participate in group education and physical activity Healthcare Team: Nursing student collaborates with physicians, patients to assess needs between appts, schedule specialist appts, and review charts | Usual care | Compared to the control group, a larger proportion of those in the intervention group had controlled BP (130/80 mmHg) at posttest (61.1% vs. 36.8%; p = 0.009) and improved BP (61.1 vs. 24.6%; p < 0.001) at posttest |
Dennison (2007) [37] 5 years; Hill (2003) [38]: 36-month outcomes | Individual: Participate in individualized care activities (all members of family engaged by healthcare team on an individual basis) Healthcare Team: Team care including nurse practitioners, community health workers, and physicians. Included a team review of medications, connecting participant with transportation, employment support; engage/mobilize family/social support | Education control and list of community hypertension care sources | There were between-group differences in systolic BP at Years 1, 3, and 4, but these were not sustained in Year 5. There were between-group differences in diastolic BP at Years 1, 3–4, but this was not sustained in Year 5 The intervention effect was not dependent on having a physician or nurse practitioner for hypertension care |
Emery-Tiburcio (2019) [39] 12 months | Individual: Complete action plan recommendations; Engage in psychotherapy (either cognitive behavioral therapy or interpersonal psychotherapy) Healthcare Team: Semi-structured assessment of mental health and cardiovascular risk followed by virtual team case review with geropsychologist, psychiatrist, social worker, chaplain, dietitian, pharmacist, occupational therapist, and primary care physician; Program coordinator would facilitate community resource engagement on behalf of participant as requested | Health education, social support, and supportive services control (“Generations” health program) | There were no significant intervention effects on systolic (p = 0.77) or diastolic (p = 0.47) BP |
Feldman (2016) [40] 12 onths | Individual: “Basic intervention”: BP self-monitoring and education with JNC7 Guide; “Augmented Intervention”: Basic Intervention and enrollment in hypertension home support program Healthcare Team: Hypertension support nurse and health educator-provided medication, self-management support for patient; Coordinate care plans and augment medication with primary care physician | Usual home health services | All groups had declining systolic BP over the trial, but there were no significant intervention effects on systolic BP at the 12-month posttest |
Gabbay (2006) [41] 12 months | Individual: Participate in individualized care plan activities Healthcare Team: Nurse care manager coordinated patient care with primary care physician, including referrals to other facilities, scheduling, medication, and therapeutic recommendations | Usual care | Compared to the control group, the intervention group had significantly improved systolic and diastolic BP at posttest (p < 0.001) |
Gabbay (2013) [42] 24 months | Individual: Participate in individualized care plan activities Healthcare Team: Nurse care manager coordinated patient care with primary care physician, including referrals to other facilities, scheduling, medication, and therapeutic recommendations | Usual care | There were no significant intervention effects on systolic BP at Year 1 (p = 0.33) but was present in Year 2 (p = 0.045) |
Gary (2003) [43] 24 months | Individual: Participate in individualized care plan activities Healthcare Team: Nurse care manager who coordinated care between the patient and physician (including referrals, counseling, physician feedback and prompting); Community health worker-facilitated preventive care (e.g., schedule appointments, mobilize social support, provide physician feedback); Biweekly intervention coordination meetings between nurse care manager, community health worker | Usual care (factorial design with nurse care manager, community health worker as separate components) | Compared to the control group, the nurse care manager and community health worker group had significantly improved diastolic BP at posttest (p < 0.042). There were no intervention effects on systolic BP |
Green (2014) [44] 6 months | Individual: Participate in BP self-monitoring and management activities Healthcare Team: Dietitian-led team care, including communicating with physicians and patients about augmenting medication management | Usual care | There were no significant intervention effects on systolic BP (p = 0.40), diastolic BP (p = 0.32), CVD risk score (p = 0.10), or the percentage of participants with BP control (p = 0.16) |
Heisler (2012) [45] 14 months | Individual: Participate in disease self-education and self-management activities provided by their physician Healthcare Team: Pharmacist–physician collaboration on medication treatment; pharmacist develops action plan with participant | Usual care | Both the intervention and control groups had decreasing systolic BP by about 9 mmHg 6 months after the intervention ended; there were no significant between-group differences. The systolic BP lowering occurred more rapidly among the intervention compared to control group (i.e., immediate posttest differences were greater among intervention) |
Hennessy (2006) [46] 6 months | Individual: Participate in disease self-education and self-management activities provided by their physician Healthcare Team: Pharmacist-delivered education to physicians; they also received physician-specific audit reports on the proportion of those with managed hypertension and percentile rank in health system | Usual care | There were no significant intervention effects on systolic or diastolic BP |
Hiss (2007) [47] 6 months | Individual: Participate in action plan for disease management Healthcare Team: Nurse care manager-led counseling for participant; Treatment plans and patient goals discussed with physician to co-develop action plan | Comprehensive diabetes evaluation and results delivered to physician | There were significant intervention effects on systolic BP (p = 0.0007) but not diastolic BP (p = 0.39) Participants with baseline systolic BP values ≥ 130 mmHg improved if they had >2 contacts with study nurse, but not if they had <2 contacts |
Hunt (2008) [48] 12 months | Individual: Participate in hypertension self-management activities Healthcare Team: Pharmacist-led discussions with patient about medications, lifestyle habits, barriers to care, education, and follow-up care | Usual care | There were significant intervention effects on systolic (p = 0.007) and diastolic (p = 0.002) BP |
Islam (2023) [49] 6 months | Individual: Participate in group education sessions; execute action plan as discussed with community health worker Healthcare Team: Community health workers engaged participants in participant goal-setting, medication adherence, and activity monitoring; provide resource linking (e.g., finding South Asian-serving organizations; connecting with food pantries) | One-time education lecture and usual care | Among those with posttest data, a greater proportion of those in the intervention group had controlled BP compared to the control group (68.2% vs. 41.6%, p < 0.001). The intervention group had 3.7 times the odds of achieving BP control at follow-up compared to the control group |
Kangovi (2017) [50] 6 months | Individual: Participate in disease self-management activities to achieve individualized goals Healthcare Team: Community health workers engaged participants in participant goal-setting, medication adherence, and activity monitoring; provide resource linking (e.g., visit food pantry with participant); Community health worker-led weekly patient support group; managers provided support, training, burnout prevention training, and review patient documents with community health workers; community health workers communicated action plans + progress to physicians | Goal-setting alone and usual care | There were clinical, albeit nonsignificant posttest differences in systolic BP favoring the intervention group (11.2 mmHg vs. 1.8 mmHg decrease, p = 0.08) |
Katon (2010) [51] 12 months; Katon (2012) [52] (18 and 24 months follow-up) | Individual: Participated in chronic disease self-management activities based on discussion with nurse–physician team Healthcare Team: Physician-nurse collaborative team to develop patient clinical and self-care goals; weekly team meetings between nurses, psychiatrists, physicians, and psychologists to review medications and clinical responses | Enhanced usual care | There were significant intervention effects on systolic BP (unadjusted between-group difference = 5.1 mmHg) at 12 months The intervention effects on systolic BP were not maintained at 18 and 24 months follow-up |
Kilbourne (2013) [53] 24 months | Individual: Participate in disease self-management activities Healthcare Team: Health specialist-delivered self-management education, wellness monitoring, clinical registry tracking, and links to community resources to participant; health specialist facilitated patient-physician communication, including relaying patient health concerns; ongoing clinical management by primary care and mental health provider team; health specialist provided summary information on bipolar disorder treatment to physicians and mental health providers | Enhanced usual care (quarterly wellness newsletters and standard care) | There were significant intervention effects on systolic (p = 0.04) and diastolic (p = 0.04) BP |
Krein (2004) [54] 18 months | Individual: Participate in disease self-monitoring activities based on treatment goals discussed with case manager Healthcare Team: Case manager-led training patients on disease self-management, including exercise and diet; provide reminders for recommended screening/tests; aid with appointment scheduling/referrals/and identify/initiate medication treatment/changes; physician or case manager collaborate on augmenting medication dosage | Usual care | There were no significant intervention effects on systolic (p = 0.53) or diastolic (p = 0.61) BP |
Lin (2014) [55] 12 months (followed up to 24 months) | Individual: Participate in disease treatment goals developed in collaboration with nurse care managers and physicians Healthcare Team: Nurse care manager monitored clinical progress and supported patient medication adherence and lifestyle changes; weekly case reviews with nurse care manager, patients’ physicians and care team, and medical and psychiatric consultants; after achieving target levels, nurse and patient co-develop relapse prevention and maintenance plan | Usual care | Among those with poorer baseline systolic BP control (>140 mmHg), there were significant intervention effects at 6 months (p = 0.012), but this effect was not sustained at 12, 18, or 24 months There were no significant intervention effects for any timepoint among those with fair systolic BP control at baseline |
Ma (2009) [56] 15 months | Individual: Participate in individualized treatment plan developed with case management team Healthcare Team: Nurse and dietitian-led case management integrated with patients’ primary care teams; referred participant to other resources/appointments as necessary | Usual care | There were significant intervention effects on both systolic (p = 0.003) and diastolic (p = 0.02) BP |
Margolis (2018) [57] 12 months (article is 54 months follow-up) | Individual: Participate in disease self-management activities Healthcare Team: Pharmacists delivered disease self-management (telehealth) education every 2 weeks until BP control was achieved, then frequency was reduced; pharmacists communicated treatment goals, progress with primary care physicians, would request medication augmentation as necessary | Usual care | There were significant intervention effects on systolic BP for the first 18 months and diastolic BP for the first 12 months. At 54 months, there were no significant intervention effects on systolic (p = 0.18) or diastolic (p = 0.37) BP |
Margolis (2022) [58] 12 months | Individual: Participate in disease self-management activities to achieve BP treatment goals; Participate in home BP telemonitoring Healthcare Team: Pharmacists delivered disease self-management (telehealth) education until BP control was achieved, then frequency was reduced; pharmacists communicated treatment goals, progress with primary care physicians, would request medication augmentation as necessary | Clinic-based care | There were significant decreases in systolic BP for both clinic-based care and telehealthcare, but there were no between-group differences in systolic BP change (p = 0.45) |
McClintock (2017) [59] 12 weeks | Individual: Participate in individualized program activities to improve antihypertensive medication adherence, hypertension control; Interventionist-delivered pharmacotherapy for depression and hypertension management; engage in patient priority planning with interventionist (i.e., personalized management plan) Healthcare Team: Interventionists developed an intervention plan with participants that addressed both biomedical, social determinants of health needs (including developing community resource guide); interventionists shared patient priorities shared with clinical team | “Basic Intervention” (i.e., individualized program and depression-hypertension treatment integration without patient prioritized plan) | Participants in the enhanced intervention (basic and patient prioritized planning) had significantly improved systolic (p = 0.003) and diastolic (p = 0.019) BP compared to the basic intervention group |
Nguyen-Huynh (2022) [60] 12 months (follow-up up to 48 months) | Individual: Participate in individualized lifestyle coaching sessions (Lifestyle Coaching condition); Participate in hypertension education activities (Enhanced Pharmacotherapy Monitoring condition) Healthcare Team: Enhanced Pharmacotherapy Monitoring condition: Research nurse coordinator and pharmacist team augmented medication treatment (e.g., optimize thiazine dosing, increase spironolactone prescribing for resistant hypertension); nurse-provided resource linking within healthcare network | Usual care | There were no significant effects of the enhanced pharmacotherapy intervention on BP control at 12, 24, and 48 months posttest. There were significant effects of the lifestyle coaching on BP control at 24 (p = 0.001) and 48 months (p = 0.006) posttest |
Planas (2012) [61] 9 months | Individual: Participate in diabetes education and coaching on self-management skills Healthcare Team: Pharmacists completed comprehensive medication audit, recommended drug therapy changes with participant and conveyed to primary care physician | Usual care | There were significant intervention effects on systolic (p = 0.01) but not diastolic (p > 0.05) BP |
Prezio (2013) [62] 12 months | Individual: Participate in 1-on-1 health coaching sessions with community health workers Healthcare Team: Community health workers facilitated physician contact, assisted participants with special visits, and provided disease self-monitoring materials (e.g., glucose monitors and testing strips) | Usual care | There were no significant intervention effects on systolic or diastolic BP |
Rosas (2015) [63] 12 months (followed up to 24 months) | Individual: Individual and group-based diet and exercise intervention (case management and case management/community health worker condition); Participate in disease self-management activities as discussed with team Healthcare Team: Care coordination with case manager (and community health worker if assigned to that condition), physician; case management/community health worker arm only: inclusion of community health worker in care coordination, fostering family support, enhancing participant success in food negotiations, identifying | Usual care | There were no significant intervention effects for either case management or case management/community health worker teams in systolic or diastolic BP at 6, 12, or 24 months Among men, those in the case management/community health worker team intervention achieved a greater systolic and diastolic BP compared to case management at 24 months (p < 0.05) |
Scott (2006) [64] 9 months | Individual: Participate in education appointments and disease self-management activities to achieve therapy goals developed with pharmacist Healthcare Team: Pharmacist-led diabetes education appointments, including referrals, implementing pharmacotherapy management recommendations approved by provider, and continuing goals/long-term plans | Usual care | At 9 months, there were significant intervention effects in systolic BP (p = 0.023). There were no significant intervention effects on diastolic BP |
Vaughan (2017) [65] 6 months | Individual: Participate in comprehensive diabetes group visits and self-management activities Healthcare Team: Community health worker-led diabetes group visits and participant support between classes, including diet and medication adherence, reminders, and resource linking, as necessary | Usual care | There were no significant intervention effects on systolic (p = 0.89) or diastolic (p = 0.39) BP There were no significant intervention effects in the percent of participants who met target BP goals for either systolic (88% in intervention vs. 88% in control; p > 0.99) or diastolic (96% in intervention vs. 92% in control; p = 0.56) BP |
Von Korff (2011) [66] 12 months | Individual: Participate in disease self-management and monitoring to achieve treatment goals Healthcare Team: Nurse, psychiatrist, primary care physician, and psychologist team meetings to review cases, patient progress; Nurse communicated drug treatment recommendations for primary care physician to enact; after achieving target levels, nurse and patient co-develop maintenance plan (and treatment intensification, if necessary) | Usual care | There were significant intervention effects on systolic BP at 6 and 12 months. At 12 months, the differences in systolic BP change between the intervention and control groups were significant (5.1 mmHg) |
Zillich (2005) [67] 3 months | Individual: One-on-one disease education sessions with pharmacist; Participate in BP self-monitoring activities Healthcare Team: Pharmacist developed treatment recommendations based on participant self-monitoring data; physician and pharmacist co-develop treatment plan targeting both medication and lifestyle | Low-intensity intervention (BP assessment by pharmacist) | Systolic BP declined in both the low- and high-intensity intervention; there were no significant between-group differences (p = 0.12) There were significant between-group differences in diastolic BP favoring the high-intensity intervention (p = 0.03) |
Individual and Healthcare Team and Health Policies | |||
Holtrop (2017) [68] 16 months | Individual: Participate in individualized behavioral changes as discussed with care manager Healthcare Team: Embedded care manager to provide patient resources (e.g., behavior change strategies, develop community resource guide) Health Policies: Care management enhancements to electronic health records (e.g., flagging gaps in chronic care, templates for disease management) | Usual care | There were no significant changes in systolic BP over time for either the intervention or control group |
Huebschmann (2012) [69] 3 months | Individual: Participate in self-management and monitoring activities Healthcare Team: Outreach coordinator worked with patients to schedule BP-focused appointments with primary care physician; would facilitate future appointment scheduling if patient BP remained elevated Health Policies: Outreach coordinator-delivered electronic prompts to physicians prior to BP-related appointments with patients (including previous BP readings; JNC 7 guidelines and treatment) | Usual care | While there were changes in clinical inertia, there were no intervention effects on systolic (p = 0.50) or diastolic (p = 0.71) BP |
Murray (2004) [70] 6 months | Individual: Receive medication counseling from pharmacists; participate in individualized treatment activities (e.g., exercise, smoking cessation) Healthcare Team: Pharmacists use computer systems to determine medication regime; serves as liaison to communicate medication changes between the participant and physician Health Policies: Computer-based treatment ordering system for physicians and/or pharmacists | Usual care (factorial design; physician and pharmacist intervention as separate components) | There were no statistical or clinically significant intervention effects on systolic or diastolic BP |
Piatt (2010) [71] 12 months (up to 3 years follow-up) | Individual: Participate in diabetes self-management education and support group (CCM intervention only) Healthcare Team: Physician diabetes education lecture on problem-based learning (Both PROV, CCM interventions); On-site certified diabetes educator for patient and/or provider consultation (CCM intervention only) Health Policies: Providers encouraged to redesign processes for seeing patients with diabetes for routine visits (CCM intervention only); Chart audit completed by certified diabetes educator (Both PROV, CCM interventions) | Usual care (chart audit report and decision support) | At 12 months, there were significant effects of both the chronic care model and provider education-only interventions on systolic BP. These results were not sustained at 36 months |
Ralston (2009) [72] 12 months | Individual: Participate in disease self-management activities after developing action plan with care manager Healthcare Team: Web-based case manager provided disease self-management education; collaborated on decision support with patient and provider; integrated patient communications in ongoing care (communicate needs with provider) Health Policies: Established provider decision support using participant self-monitoring inputs (e.g., glucose reading) | Usual care | There were no significant intervention effects on systolic (p = 0.93) or diastolic (p = 0.91) BP |
Rothman (2005) [73] 12 months | Individual: Disease education and counseling, medication management training from pharmacists Healthcare Team: Diabetes care coordinator available for patients to discuss barriers to care, health education, insurance problems, or low health literacy; Pharmacists available for one-on-one or joint appointments with the patient and physician Health Policies: Evidence-based treatment algorithms applied to improve medication use | One-time management session from pharmacist and usual care | The intervention group had significantly greater improvement in systolic BP compared to the control group (difference of 9 mmHg) |
Roumie (2006) [74] 6 months | Individual: Educational information on lifestyle modifications and medication adherence for improving BP control. The letter also linked to the American Heart Association for more details, e.g., disease self-management information Healthcare Team: Physician educational email on the JCN 7 guidelines for treating hypertension Health Policies: Electronic notification sent to the physician by the pharmacy including dates and values of patient’s last 3 BP measures and offered treatment options | Factorial design comparing provider education alone, provider education and alert, and provider education and alert and patient education | Those who received the provider education and alert and patient education intervention had better BP control; providers of those in this intervention also reported more patients with a systolic BP of 140 mmHg or less. There were no significant intervention effects on diastolic BP |
Schoenthaler (2020) [75] 6 months | Individual: Participate in health coaching sessions with medical assistants to improve medication adherence Healthcare Team: Physician-medical assistant “teamlets” collaborate on patient care Health Policies: Office system support: use EHR to identify Latino patients with uncontrolled hypertension to refer them to bilingual medical assistant | Usual care | There were significant improvements in systolic and diastolic BP for both groups; there were no significant intervention effects for either outcome |
Svarstad (2013) [76] 6 months (up to 12 month outcomes) | Individual: Take-home toolkits including pedometer, medication boxes, BP self-management information packets; received self-report tools from pharmacists Healthcare Team: Team-based training for pharmacists, pharmacy technicians on how to use clinical tools to address patient barriers and improve BP control Health Policies: Clinical toolkits that included algorithms to address patient barriers, provide physician feedback; Developing an on-site BP clinic (including providing furniture and equipment for a semiprivate BP station) for pharmacists to deliver counseling, tailored intervention, and patient tool kit | Information pamphlet on BP control for patients; letter with JNC-7 guidelines to physicians and pharmacists | At 6 months, intervention participants had significantly better systolic BP changes (−12.62 vs. −5.31 mm Hg, p < 0.001), greater BP control (50% vs. 36%, p = 0.01), and greater medication refill adherence (60% vs. 34%, p < 0.001). At 12 months (6 months after discontinuation), refill adherence (p < 0.001) and systolic BP (p = 0.004) were still better in the intervention group, but BP control was not different (p > 0.05) |
Svetkey (2009) [77] 18 months | Individual: Group-based diet, physical activity, and medication adherence intervention Healthcare Team: Physician training modules on JNC-7 guidelines (counted toward CME credits); Community health advisors offered lifestyle counseling for participants during, after group-based intervention Health Policies: Treatment algorithm and decision tree based on JNC-7 guidelines; physicians completed quality improvement forms that were converted to personalized quarterly feedback forms | MD-Control: Usual care for physician Patient-Control: One-time interventionist visit to receive advice, written materials | At 6 months, there was a significant effect of the physician and patient intervention on systolic BP (p = 0.03; decrease of 9.7 mmHg). Differences between the groups did not persist at 18 months |
Talavera (2021) [78] 6 months | Individual: Participate in group-health education classes led by community health workers; Participate in disease self-management activities to achieve treatment goals Healthcare Team: Shared treatment plan between physician and specialty behavioral health provider and care coordination to facilitate treatment; up to 4 integrated medical visits with physician, specialty behavioral health provider; collaboration between physician, patient, and specialty behavioral health provider on treatment goals Health Policies: Co-location of clinical team, warm hand-off from medical to specialty behavioral health provider | Usual care | There were no significant intervention effects on systolic (p = 0.86) or diastolic (p = 0.09) BP |
Towfighi (2021) [79] 12 months | Individual: Participate in disease self-management and monitoring activities to achieve health goals Healthcare Team: Community health workers addressed medication adherence; provided education and self-management training; offered resources/referrals to participants to address social determinants of health; served as a liaison between patients, healthcare system; conducted at least 3 home visits; participants offered at least 3 advanced practice clinician meetings, where medication was prescribed/titrated Health Policies: Electronic decision support for clinicians; protocol-driven risk factor management | Usual care | There were no significant intervention effects for systolic BP (p = 0.46). When restricted to those with baseline systolic BP ≤ 130 mmHg, a similar nonsignificant result was found (p = 0.57) |
Vinicor (1987) [80] 2 months (followed up to 26 months) | Individual: Participate in disease self-management education training Healthcare Team: Physician education on common diabetes problems and management/diagnostic strategies for handling problems; following physician seminars, “Consultation Conference” small group discussions with faculty and residents to discuss protocol implementation issues Health Policies: Protocol-based physician reminders | Usual care (factorial design comparing usual care, patient education, physician education, or patient and physician education) | There were no intervention effects on systolic BP. There were significant effects of the patient and physician education intervention on diastolic BP (effect size = 0.47) |
Wang (2012) [81] 18 months | Individual: Participate in disease self-monitoring activities; those maintaining adequate BP control did not activate intervention Healthcare Team: If home BP control was inadequate, nurse contacted patients to administer tailored modules to improve self-management; medication management condition: Nurse notified physician when medication treatment needed to be augmented Health Policies: Medication management condition: Nurses provided standardized, evidence-based decision support tool for hypertension medication management | Usual care (4 conditions: usual care, behavioral management alone, medication management alone, or behavioral and medication management) | Participants who received either behavior management alone or medication management alone showed significant gains in BP control at 12 months, but these effects were not sustained at 18 months. There was no significant effect of combined management on BP control |
Welch (2011) [82] 12 months | Individual: Participate in diabetes education course and self-management activities Healthcare Team: Nurse who leads diabetes education coordinates diabetes medication treatment with primary care physician Health Policies: Patient risk profiles developed from participant’s lab results, including summary of diabetes self-management behaviors and barriers for physicians to discuss with participant | Educational control | There were no significant intervention effects on systolic (p = 0.11) or diastolic (p = 0.17) BP. There were also no significant intervention effects on the percentage of patients with BP < 130/80 mmHg (p = 0.09) |
Individual and Community Environment | |||
Ard (2017) [83] 6 months | Individual: Group weight loss intervention targeting physical activity and diet Community Environment: County-level grants that key stakeholders could apply to support local initiatives (e.g., community garden, enhance walking trail) | Weight loss only intervention | Both groups had significant reductions in systolic BP (weight loss only: 1.9 mmHg; weight loss plus: 4.0 mmHg) and diastolic BP: (weight loss only: 1.7 mmHg; weight loss plus: 2.9 mmHg). No between-group differences |
Brewer (2022) [84] 6 months | Individual: Psychoeducation on hypertension management; participation in diet or physical activity “lifestyle journey” Community Environment: Between-church competition/social incentives; church-level self-monitoring posted in public areas | Delayed intervention | No significant intervention effects on systolic BP (p = 0.14) or diastolic BP (p = 0.37), but the intervention significantly improved the overall Life’s Simple 7 score |
Brown (2015) [85] 12 months | Individual: Self-help materials for BP Community Environment: Environmental and social changes encouraged in the parish, including food provided at parish functions and providing church programs to encourage healthy cooking, physical activity | Active control (received skin cancer awareness materials) | No significant intervention effect for systolic BP (p = 0.86) or diastolic BP (p = 0.16) |
Derose (2019) [86] 5 months | Individual: Participate in physical activity, nutrition, education classes Community Environment: Community garden grown on church grounds, maintained by church members; inventory of local food and exercise establishments identified; church members brainstorm points for advocacy | Waitlist control | There were no significant intervention effects on systolic (p = 0.80) or diastolic (p = 0.75) BP |
Kerr (2018) [87] 12 months | Individual: Developed goals with peer leader in 1-on-1 sessions; Participated in individual counseling and physical activity self-monitoring, group education sessions, and group walking sessions Community Environment: Peer leaders advocated for local environment improvements (e.g., walk audits, received training on engaging with policy makers and city officials) | Healthy aging control (attention and social control who received 9 group education sessions and 4 general health calls) | There were significant intervention effects for systolic (p < 0.01) and diastolic (p < 0.05) BP at 6 months, but this was not sustained at 12 months |
Nafziger (2001) [88] 5 years | Individual: Participate in wellness activities, including education, lifestyle activities, and health screening events Community Environment: Local health committees developed in 24 communities to develop health promotion programs tailored to community’s needs; Community leaders formed “Healthy Heart Advisory Committees” to provide general guidance; Engaging local media outlets to deliver education materials; Development of local walking groups; Workplace and neighborhood risk factor screening | Usual care | Systolic BP was significantly improved among the intervention group, but there were no intervention effects for diastolic BP |
Paskett (2018) [89] 12 months | Individual: Walking by Faith: Participate in diet intervention activities to meet individualized health goals Ribbons of Faith: Participate in education sessions; church members encouraged to complete cancer screenings Community Environment: Walking by Faith: Community navigators, project staff co-developed strategies to support environmental approaches to increase physical activity, including setting up walking courses, group walks, walking challenges; identified safe walking paths; used donations from local businesses and organizations to encourage exercise Ribbons of Faith: Health fairs; cancer education inserts shared in church bulletins | Compared two interventions (Ribbons of Faith vs. Walking by Faith) | There were no significant effects in systolic BP for either the Walk by Faith or Ribbons of Faith intervention |
Seguin (2018) [90] 6 months | Individual: Skills-based classes on nutrition and physical activity Community Environment: HEART Club civic engagement, including development of community guides with resources for health, healthcare and wellness, and community change; HEART Clubs identified environmental issues relevant to their community, followed system to article and evaluate action steps to advocate for community change | Education-only control | There were no significant intervention effects on systolic (p = 0.37) or diastolic (p = 0.37) BP |
Seguin-Fowler (2020) [91] 6 months | Individual: Skills-based classes on nutrition and physical activity; group discussions on building social support for exercising, improving diet outside of fitness courses Community Environment: Increased civic engagement, including grocery store tours and town walking audits; HEART clubs identified environmental issues relevant to their community, followed system to article and evaluate action steps to advocate for community change | Delayed intervention control | There were no significant intervention effects on systolic or diastolic BP, but there were significant intervention effects on the Life’s Simple 7 total score (p < 0.001). The intervention effect on Life’s Simple 7 was not present when restricted to adults > 60 years old |
Individual and Family/Social Support | |||
Baranowski (1990) [92] 14 weeks | Individual: Individual fitness goals during exercise component Family/Social Support: Family-level behavioral counseling, education (separate for children and parents), aerobic activity, and snacks | No-contact control | No significant changes in BP for parents or children except in fourth-phase diastolic BP among children favoring the intervention group |
Matthan (2022) [93] 12 months | Individual: Group-based physical activity for children Family/Social Support: Families received education materials on diet, exercise; families participated in skill-building group activities (e.g., cooking); Parents-only education/support sessions | Usual care | There were no significant intervention effects for either systolic (p = 0.779) or diastolic (p = 0.786) BP. There were no changes in BP over time for either treatment condition |
Rosland (2022) [94] 12 months (followed up to 15 months) | Individual: Participate in disease self-management coaching session with care partner; one-on-one health coaching sessions to discuss progress on achieving health goals Family/Social Support: One-on-one health coaching sessions to discuss how to support participant’s disease self-management activities; participate in preparation calls before scheduled clinic visits with participant, dyad coach | Enhanced usual care (disease self-management materials) | There were no significant intervention effects on systolic BP (p = 0.18) |
Trief (2016) [95]; Trief (2019) [96] 4 months (followed up to 12 months) | Individual: Participate in comprehensive diabetes education (all training arms); participate in disease self-management intervention (individual calls) Family/Social Support: Participate in couples’ self-management intervention (couples calls) | Usual care (diabetes self-management education) | There were no significant intervention effects on systolic or diastolic BP for participants with type 2 diabetes There were no significant intervention effects on systolic BP for care partners of those with type 2 diabetes. There were significant intervention effects on diastolic BP at 4, 8, and 12 months (couples counseling > diabetes education; couples counseling > individual counseling at 12 months only). There were also significant effects of the individual counseling on their care partner’s diastolic BP at 4 months (compared to diabetes education), but this was not sustained |
Wieland (2018) [97] 12 months | Individual: Participate in individual health goal setting with family health promoter; engage in activities to meet health goals Family/Social Support: Participate in family health goal setting with family health promoter, home visits, and education activities | Delayed intervention | There were no significant intervention effects on systolic or diastolic BP at 6 (p = 0.11 and 0.41, respectively) or 12 months (p = 0.13 and 0.48, respectively) |
Yates (2015) [98] 6 months (30-year trajectories modeled) | Individual: Participate in individual counseling, education, and goal-setting activities (spouse/partner); participate in individual counseling, education, and goal-setting activities (participant who underwent coronary artery bypass Family/Social Support: Participate in group fitness activities with participant and spouse/partner | Usual care (education and counseling advice) | There was a marginally significant intervention effect on 30-year estimated systolic BP on the spouse/partner (partial eta-squared = 0.002, p = 0.06) |
Individual and Family/Social Support and Healthcare Team | |||
Haskell (2006) [99] 12 months | Individual: Participate in disease self-management activities Family/Social Support: Family activated by disease management team to support participants risk-reduction efforts Healthcare Team: Physician, nurse/nurse practitioner, and dietitian co-developed treatment plan (including lifestyle and medical management) | Usual care | There were significant posttest differences in systolic and diastolic BP favoring the intervention group (p < 0.01) |
Levine (2003) [100] 40 months | Individual: Participate in community high BP education and educational pamphlet; Participate in lifestyle/behavioral activities to meet treatment goals discussed with community health worker Family/Social Support: Family or friends of participant taught how to provide functional, social support by community health worker Healthcare Team: Conduct home visits with participants to provide education, lifestyle support, resource linking, and access to care, health insurance, or other system-related factors | Psychoeducational control (education and pamphlet only) | There were no significant intervention effects on systolic or diastolic BP |
Pearce (2008) [101] 12 months | Individual: Participate in individualized patient education session with support person; patient-specific educational newsletters on cardiovascular risk factor control Family/Social Support: Participate in individualized patient education session; support person-specific educational newsletters on facilitating cardiovascular risk factor control Healthcare Team: Registered nurse patient educator delivered education sessions and newsletters | Individualized patient education without inclusion of support person education | There were no significant intervention effects on systolic BP |
Pérez-Escamilla (2015) [102] 12 months (followed up to 18 months) | Individual: Participate in tailored intervention activities to achieve treatment goals (e.g., self-monitoring, medication adherence, nutrition) Family/Social Support: Families allowed to participate during home sessions with participant, community health worker if endorsed by participant Healthcare Team: Community health worker and participant co-developed type 2 diabetes self-management plan; community health worker participated in weekly meetings with primary care physicians’ medical teams and dieticians to discuss treatment options, participant concerns or barriers | Usual care | There were no significant intervention effects on systolic BP across 3, 6, 12, or 18 months (p range: 0.279–0.313.) |
Healthcare Team and Health Policies | |||
Petersen (2013) [103] 20 months | Healthcare Team: Physicians received financial incentives for achieving BP control, appropriately responding to uncontrolled BP, and/or prescribing antihypertensive medications; physician financial incentives provided from directors of participating regional hospitals (contributed USD 250,000) Health Policies: Practice-level incentives for achieving BP control, appropriately responding to uncontrolled BP, and/or prescribing antihypertensive medications (regardless of randomization to individual component) | Usual care (Factorial design comparing individual-level incentives, practice-level incentives, and combination vs. usual care) | Individual but not practice-level or combined incentives resulted in greater BP control. This effect was not sustained after a washout period of 18 months |
Peterson (2008) [104] 12 months (up to 24 months follow-up) | Healthcare Team: Practice redesign including establishment of local physician champion who facilitated previsit planning, physician reminders Health Policies: Electronic diabetes registry of high-risk participants to track operational activity, clinical measures; reports reviewed in monthly team meetings | Usual care | The percentage of patients who met the target BP levels was significantly higher among the intervention clinics (p = 0.05) |
Weber (2010) [105] 9 months | Healthcare Team: Pharmacist–physician team develop medication regimen for patient, incorporating clinical pharmacist’s patient interview Health Policies: Clinical pharmacists reviewed patient data, interviewed patients to identify current treatment strategies, potential barriers to achieving BP goals (met at least 1x/every 2 months) | Usual care | Ambulatory systolic BP was reduced to a greater extent in the intervention compared to control group (daytime systolic BP, nighttime systolic BP, 24-h systolic BP; p < 0.001). More participants in the intervention had controlled BP at the study end compared to controls (24-h BP; p < 0.001) |
Individual and Healthcare Team and Community Environment | |||
Victor (2011) [106]; Rader (2013) [107] subgroup analysis 10 months | Individual: Attend healthcare and barber appointments (receive a free haircut for every high BP referral card signed by physician and returned to barber) Healthcare Team: Customers who did not have physicians were connected with local community physicians and safety-net clinics Community Environment: BP checks offered during haircuts at local barbershop; personalized peer-based health messaging incorporated through conversations, posters, and barbers modeling desired treatment-seeking behavior; barbers received incentives per customer’s recorded BP, referral, and BP cards returned by patrons with physician’s signature (documenting physician–customer contact) | AHA-provided pamphlets (High Blood Pressure in African Americans) made available to control barbershops | There was no significant effect of the intervention on diastolic BP, but there was a marginal intervention effect for systolic BP change (p = 0.08) When barbers referred customers to hypertension specialists, there was a systolic BP reduction of 21 mmHg (p < 0.0001) compared to the control. When referred to primary care physicians, there were no significant differences compared to the control group (4 mmHg; p = 0.31) |
Victor (2018) [108]; Victor (2019) [109] 6 months (followed up to 12 months) | Individual: Participants invited to share health stories with pharmacist to display on barbershop walls Healthcare Team: Pharmacists collaborated with physician hypertension specialists on treatment regimen Community Environment: Pharmacists stationed in barbershops to prescribe medication, assess BP and plasma electrolyte levels, and encourage lifestyle changes; barbers encouraged participants to follow-up with pharmacists, trained on BP assessment | Educational materials and BP screener | At 6 months, the mean reduction in systolic BP was 21.6 mmHg greater in the intervention compared to control group (p < 0.001). The mean reduction in diastolic BP was 14.9 mmHg greater in the intervention compared to control group (p < 0.001). A BP level of less than 130/80 mmHg was achieved among 63.6% of the intervention vs. 11.7% of the control (p < 0.001) At 12 months, the mean reduction in systolic BP was 20.8 mmHg greater in the intervention compared to control group (p < 0.0001). The mean reduction in diastolic BP was 14.5 mmHg greater in the intervention compared to control group (p < 0.0001). A BP level of less than 130/80 mmHg was achieved among 68% of the intervention vs. 11% of the control (p < 0.02) |
Individual and Community Environment and Health Policies | |||
Pereira (2020) [110] 12 months | Individual: Education, behavioral cues, goal-setting, and relapse prevention provided through newsletters, 1-on-1 coaching sessions (both STAND+, MOVE+ conditions) Community Environment: Desk-based ergonomic setup at work (e.g., standing desks) (STAND+ condition only) Health Policies: Establishment of workplace health leaders and advocates to provide links between worksite employees, management, and study team (both STAND+, MOVE+ conditions); Worksite leaders and advocates share new intervention initiatives with employees (both STAND+, MOVE+ conditions) | Comparison of two interventions (MOVE+ vs. STAND+) | There were no significant between-group differences in either systolic or diastolic BP When restricting the analysis to those with dysgylcemia, the effect of the STAND+ on systolic BP was stronger, albeit nonsignificant (difference [95% CI] −6.6 [−15, 1.7]) |
Wilcox (2013) [111] 15 months | Individual: Church leadership and kitchen staff participate in didactic training on physical activity, healthy eating, and adopting meals to meet DASH recommendations; Church leaders monitor healthful behaviors (e.g., wear pedometer, disseminate health information from pulpit) Community Environment: Churches provide physical activity programs at church; offer physical activity before or during services; provide exercise equipment at churches; provide skills-based classes; church leadership negotiate for discounted YMCA membership; lobby for community centers; Establish a physical activity ambassador who incorporates physical activity into church functions; Use competitions between churches to increase enjoyment, incentivize activities; Have pastors lead efforts in growing gardens, attend farmer’s market Health Policies: Establish a church health commission; Pastor reports to include physical activity, healthy eating activities for accountability; Update church policies for food and drink at all events; provide certificates for cooks who attend training and adhere to guidelines; churches received up to USD 1000 to assist with implementing health action plan | Delayed intervention | There were no significant intervention effects on systolic (p = 0.58) or diastolic (p = 0.91) BP |
Individual and Health Policies | |||
Skolarus (2023) [112] 12 months | Individual: Receive tailored healthy behavior text messages, including recommendations on where to find discounted medications; prompted self-managed BP monitoring with personalized feedback Health Policies: Facilitated scheduling, transportation to primary care appointments | Passive monthly text reminders (factorial design comparing 3 mHealth strategies) | Systolic BP declined similarly across all groups; there were no significant differences by intervention group |
Individual and Family/Social Support and Healthcare Team and Community Environment | |||
Campbell (2014) [113] 5 years | Individual: Child attended full-day childcare 5 days/week, 50 weeks/year, for 5 years, starting at 2 months old Family/Social Support: Parents received social service support as requested Healthcare Team: Medical team conducted physical exams and counseled parents on child health, nutrition, growth, and development Community Environment: Childcare center provided free primary pediatric care, nutrition, and referrals as appropriate | Usual care | At age 30, men from the intervention group had significantly lower systolic BP (p = 0.018) and diastolic BP (p = 0.024). There were no significant effects for women. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Sprague, B.N.; Forster, A.K. Multilevel Interventions Demonstrate Mixed Effectiveness for Improving Blood Pressure Outcomes: A Rapid Review. Healthcare 2025, 13, 1397. https://doi.org/10.3390/healthcare13121397
Sprague BN, Forster AK. Multilevel Interventions Demonstrate Mixed Effectiveness for Improving Blood Pressure Outcomes: A Rapid Review. Healthcare. 2025; 13(12):1397. https://doi.org/10.3390/healthcare13121397
Chicago/Turabian StyleSprague, Briana N., and Anna K. Forster. 2025. "Multilevel Interventions Demonstrate Mixed Effectiveness for Improving Blood Pressure Outcomes: A Rapid Review" Healthcare 13, no. 12: 1397. https://doi.org/10.3390/healthcare13121397
APA StyleSprague, B. N., & Forster, A. K. (2025). Multilevel Interventions Demonstrate Mixed Effectiveness for Improving Blood Pressure Outcomes: A Rapid Review. Healthcare, 13(12), 1397. https://doi.org/10.3390/healthcare13121397